| Symbol |
Name |
|
A1CF
|
APOBEC1 complementation factor
|
|
A2M
|
alpha-2-macroglobulin
|
|
AACS
|
acetoacetyl-CoA synthetase
|
|
AANAT
|
aralkylamine N-acetyltransferase
|
|
AATF
|
apoptosis antagonizing transcription factor
|
|
AATK
|
apoptosis-associated tyrosine kinase
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA5
|
ATP-binding cassette, sub-family A (ABC1), member 5
|
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7
|
|
ABCB9
|
ATP-binding cassette, sub-family B (MDR/TAP), member 9
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCC5
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 5
|
|
ABCD2
|
ATP-binding cassette, sub-family D (ALD), member 2
|
|
ABCD4
|
ATP-binding cassette, sub-family D (ALD), member 4
|
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1
|
|
ABHD16A
|
abhydrolase domain containing 16A
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ABR
|
active BCR-related
|
|
ACAN
|
aggrecan
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACER2
|
alkaline ceramidase 2
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACIN1
|
apoptotic chromatin condensation inducer 1
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACKR2
|
atypical chemokine receptor 2
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACKR4
|
atypical chemokine receptor 4
|
|
ACOX1
|
acyl-CoA oxidase 1, palmitoyl
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ACSF2
|
acyl-CoA synthetase family member 2
|
|
ACSF3
|
acyl-CoA synthetase family member 3
|
|
ACSL4
|
acyl-CoA synthetase long-chain family member 4
|
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
|
ACTN1
|
actinin, alpha 1
|
|
ACTN2
|
actinin, alpha 2
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ACTN4
|
actinin, alpha 4
|
|
ACVR1
|
activin A receptor, type I
|
|
ACVR1B
|
activin A receptor, type IB
|
|
ACVR1C
|
activin A receptor, type IC
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADA
|
adenosine deaminase
|
|
ADAD1
|
adenosine deaminase domain containing 1 (testis-specific)
|
|
ADAD2
|
adenosine deaminase domain containing 2
|
|
ADAL
|
adenosine deaminase-like
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM11
|
ADAM metallopeptidase domain 11
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM2
|
ADAM metallopeptidase domain 2
|
|
ADAM20P1
|
ADAM metallopeptidase domain 20 pseudogene 1
|
|
ADAM22
|
ADAM metallopeptidase domain 22
|
|
ADAM23
|
ADAM metallopeptidase domain 23
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADAMDEC1
|
ADAM-like, decysin 1
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS20
|
ADAM metallopeptidase with thrombospondin type 1 motif, 20
|
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
|
ADAMTS8
|
ADAM metallopeptidase with thrombospondin type 1 motif, 8
|
|
ADAMTSL4
|
ADAMTS-like 4
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADARB1
|
adenosine deaminase, RNA-specific, B1
|
|
ADARB2
|
adenosine deaminase, RNA-specific, B2 (non-functional)
|
|
ADAT1
|
adenosine deaminase, tRNA-specific 1
|
|
ADAT2
|
adenosine deaminase, tRNA-specific 2
|
|
ADAT3
|
adenosine deaminase, tRNA-specific 3
|
|
ADCY10
|
adenylate cyclase 10 (soluble)
|
|
ADD3
|
adducin 3 (gamma)
|
|
ADGRB1
|
adhesion G protein-coupled receptor B1
|
|
ADGRE1
|
adhesion G protein-coupled receptor E1
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
ADGRG1
|
adhesion G protein-coupled receptor G1
|
|
ADGRV1
|
adhesion G protein-coupled receptor V1
|
|
ADH5
|
alcohol dehydrogenase 5 (class III), chi polypeptide
|
|
ADH5P2
|
alcohol dehydrogenase 5 (class III), chi polypeptide, pseudogene 2
|
|
ADH5P3
|
alcohol dehydrogenase 5 (class III), chi polypeptide, pseudogene 3
|
|
ADH5P4
|
alcohol dehydrogenase 5 (class III), chi polypeptide, pseudogene 4
|
|
ADIG
|
adipogenin
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADK
|
adenosine kinase
|
|
ADM
|
adrenomedullin
|
|
ADNP
|
activity-dependent neuroprotector homeobox
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
ADRM1
|
adhesion regulating molecule 1
|
|
AEBP1
|
AE binding protein 1
|
|
AEN
|
apoptosis enhancing nuclease
|
|
AES
|
amino-terminal enhancer of split
|
|
AFAP1L2
|
actin filament associated protein 1-like 2
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGGF1
|
angiogenic factor with G patch and FHA domains 1
|
|
AGK
|
acylglycerol kinase
|
|
AGPAT1
|
1-acylglycerol-3-phosphate O-acyltransferase 1
|
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHCTF1
|
AT hook containing transcription factor 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AIF1L
|
allograft inflammatory factor 1-like
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AIFM2
|
apoptosis-inducing factor, mitochondrion-associated, 2
|
|
AIFM3
|
apoptosis-inducing factor, mitochondrion-associated, 3
|
|
AIMP1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
|
|
AIMP1P1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 pseudogene 1
|
|
AIMP2
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
|
|
AIPL1
|
aryl hydrocarbon receptor interacting protein-like 1
|
|
AIRE
|
autoimmune regulator
|
|
AJAP1
|
adherens junctions associated protein 1
|
|
AJUBA
|
ajuba LIM protein
|
|
AKAP11
|
A kinase (PRKA) anchor protein 11
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKAP17A
|
A kinase (PRKA) anchor protein 17A
|
|
AKAP4
|
A kinase (PRKA) anchor protein 4
|
|
AKIRIN2
|
akirin 2
|
|
AKR1C2
|
aldo-keto reductase family 1, member C2
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKTIP
|
AKT interacting protein
|
|
ALB
|
albumin
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2
|
|
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALDH6A1
|
aldehyde dehydrogenase 6 family, member A1
|
|
ALDOB
|
aldolase B, fructose-bisphosphate
|
|
ALDOC
|
aldolase C, fructose-bisphosphate
|
|
ALG1
|
ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALMS1
|
Alstrom syndrome protein 1
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ALX3
|
ALX homeobox 3
|
|
ALX4
|
ALX homeobox 4
|
|
AMBN
|
ameloblastin (enamel matrix protein)
|
|
AMBP
|
alpha-1-microglobulin/bikunin precursor
|
|
AMELX
|
amelogenin, X-linked
|
|
AMH
|
anti-Mullerian hormone
|
|
AMHR2
|
anti-Mullerian hormone receptor, type II
|
|
AMICA1
|
adhesion molecule, interacts with CXADR antigen 1
|
|
AMIGO1
|
adhesion molecule with Ig-like domain 1
|
|
AMIGO2
|
adhesion molecule with Ig-like domain 2
|
|
AMIGO3
|
adhesion molecule with Ig-like domain 3
|
|
AMOT
|
angiomotin
|
|
AMOTL1
|
angiomotin like 1
|
|
AMPH
|
amphiphysin
|
|
AMTN
|
amelotin
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPT4
|
angiopoietin 4
|
|
ANGPTL1
|
angiopoietin-like 1
|
|
ANGPTL3
|
angiopoietin-like 3
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANK1
|
ankyrin 1, erythrocytic
|
|
ANKRD54
|
ankyrin repeat domain 54
|
|
ANLN
|
anillin, actin binding protein
|
|
ANOS1
|
anosmin 1
|
|
ANTXR1
|
anthrax toxin receptor 1
|
|
ANXA1
|
annexin A1
|
|
ANXA11
|
annexin A11
|
|
ANXA3
|
annexin A3
|
|
ANXA4
|
annexin A4
|
|
ANXA5
|
annexin A5
|
|
ANXA9
|
annexin A9
|
|
AOC3
|
amine oxidase, copper containing 3
|
|
AP1B1
|
adaptor-related protein complex 1, beta 1 subunit
|
|
AP1G1
|
adaptor-related protein complex 1, gamma 1 subunit
|
|
AP1S1
|
adaptor-related protein complex 1, sigma 1 subunit
|
|
AP1S2
|
adaptor-related protein complex 1, sigma 2 subunit
|
|
AP1S3
|
adaptor-related protein complex 1, sigma 3 subunit
|
|
AP2A1
|
adaptor-related protein complex 2, alpha 1 subunit
|
|
AP2A2
|
adaptor-related protein complex 2, alpha 2 subunit
|
|
AP2S1
|
adaptor-related protein complex 2, sigma 1 subunit
|
|
AP3B1
|
adaptor-related protein complex 3, beta 1 subunit
|
|
AP3B2
|
adaptor-related protein complex 3, beta 2 subunit
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APBA1
|
amyloid beta (A4) precursor protein-binding, family A, member 1
|
|
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)
|
|
APC
|
adenomatous polyposis coli
|
|
APCS
|
amyloid P component, serum
|
|
APH1A
|
APH1A gamma secretase subunit
|
|
APH1B
|
APH1B gamma secretase subunit
|
|
API5
|
apoptosis inhibitor 5
|
|
APIP
|
APAF1 interacting protein
|
|
APITD1
|
apoptosis-inducing, TAF9-like domain 1
|
|
APLP1
|
amyloid beta (A4) precursor-like protein 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA2
|
apolipoprotein A-II
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOC1
|
apolipoprotein C-I
|
|
APOC2
|
apolipoprotein C-II
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APOL2
|
apolipoprotein L, 2
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AQP4
|
aquaporin 4
|
|
ARC
|
activity-regulated cytoskeleton-associated protein
|
|
AREG
|
amphiregulin
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARFGEF1
|
ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)
|
|
ARFGEF2
|
ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited)
|
|
ARHGAP17
|
Rho GTPase activating protein 17
|
|
ARHGAP27
|
Rho GTPase activating protein 27
|
|
ARHGAP4
|
Rho GTPase activating protein 4
|
|
ARHGAP5
|
Rho GTPase activating protein 5
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta
|
|
ARHGDIG
|
Rho GDP dissociation inhibitor (GDI) gamma
|
|
ARHGEF11
|
Rho guanine nucleotide exchange factor (GEF) 11
|
|
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12
|
|
ARHGEF16
|
Rho guanine nucleotide exchange factor (GEF) 16
|
|
ARHGEF17
|
Rho guanine nucleotide exchange factor (GEF) 17
|
|
ARHGEF18
|
Rho/Rac guanine nucleotide exchange factor (GEF) 18
|
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2
|
|
ARHGEF3
|
Rho guanine nucleotide exchange factor (GEF) 3
|
|
ARHGEF4
|
Rho guanine nucleotide exchange factor (GEF) 4
|
|
ARHGEF6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ARHGEF9
|
Cdc42 guanine nucleotide exchange factor (GEF) 9
|
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like)
|
|
ARL4A
|
ADP-ribosylation factor-like 4A
|
|
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2
|
|
ARR3
|
arrestin 3, retinal (X-arrestin)
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ART4
|
ADP-ribosyltransferase 4 (Dombrock blood group)
|
|
ARVCF
|
armadillo repeat gene deleted in velocardiofacial syndrome
|
|
ASAH2
|
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2
|
|
ASB1
|
ankyrin repeat and SOCS box containing 1
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASGR1
|
asialoglycoprotein receptor 1
|
|
ASGR2
|
asialoglycoprotein receptor 2
|
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing)
|
|
ASPN
|
asporin
|
|
ASS1
|
argininosuccinate synthase 1
|
|
ASTN1
|
astrotactin 1
|
|
ATF5
|
activating transcription factor 5
|
|
ATG3
|
autophagy related 3
|
|
ATG5
|
autophagy related 5
|
|
ATHL1
|
ATH1, acid trehalase-like 1 (yeast)
|
|
ATL1
|
atlastin GTPase 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATOH1
|
atonal homolog 1 (Drosophila)
|
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1
|
|
ATP4B
|
ATPase, H+/K+ exchanging, beta polypeptide
|
|
ATP5A1
|
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle
|
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
|
|
ATP6V1H
|
ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKB
|
aurora kinase B
|
|
AURKC
|
aurora kinase C
|
|
AVEN
|
apoptosis, caspase activation inhibitor
|
|
AVP
|
arginine vasopressin
|
|
AVPR1A
|
arginine vasopressin receptor 1A
|
|
AVPR1B
|
arginine vasopressin receptor 1B
|
|
AXIN1
|
axin 1
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
AZU1
|
azurocidin 1
|
|
B2M
|
beta-2-microglobulin
|
|
B3GALNT1
|
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)
|
|
B3GNT5
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5
|
|
B3GNTL1
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1
|
|
B4GALNT2
|
beta-1,4-N-acetyl-galactosaminyl transferase 2
|
|
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAG2
|
BCL2-associated athanogene 2
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAG4
|
BCL2-associated athanogene 4
|
|
BAG5
|
BCL2-associated athanogene 5
|
|
BAG6
|
BCL2-associated athanogene 6
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAMBI
|
BMP and activin membrane-bound inhibitor
|
|
BANK1
|
B-cell scaffold protein with ankyrin repeats 1
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BARHL1
|
BarH-like homeobox 1
|
|
BARX1
|
BARX homeobox 1
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BBS2
|
Bardet-Biedl syndrome 2
|
|
BBS4
|
Bardet-Biedl syndrome 4
|
|
BBS7
|
Bardet-Biedl syndrome 7
|
|
BBS9
|
Bardet-Biedl syndrome 9
|
|
BCAM
|
basal cell adhesion molecule (Lutheran blood group)
|
|
BCAN
|
brevican
|
|
BCAP29
|
B-cell receptor-associated protein 29
|
|
BCAP31
|
B-cell receptor-associated protein 31
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L10
|
BCL2-like 10 (apoptosis facilitator)
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L12
|
BCL2-like 12 (proline rich)
|
|
BCL2L13
|
BCL2-like 13 (apoptosis facilitator)
|
|
BCL2L14
|
BCL2-like 14 (apoptosis facilitator)
|
|
BCL2L15
|
BCL2-like 15
|
|
BCL2L2
|
BCL2-like 2
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCL6B
|
B-cell CLL/lymphoma 6, member B
|
|
BCL7A
|
B-cell CLL/lymphoma 7A
|
|
BCL7B
|
B-cell CLL/lymphoma 7B
|
|
BCL7C
|
B-cell CLL/lymphoma 7C
|
|
BCL9
|
B-cell CLL/lymphoma 9
|
|
BCL9L
|
B-cell CLL/lymphoma 9-like
|
|
BCLAF1
|
BCL2-associated transcription factor 1
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEX2
|
brain expressed X-linked 2
|
|
BFAR
|
bifunctional apoptosis regulator
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BHLHE23
|
basic helix-loop-helix family, member e23
|
|
BICD2
|
bicaudal D homolog 2 (Drosophila)
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIN1
|
bridging integrator 1
|
|
BIN3
|
bridging integrator 3
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC6
|
baculoviral IAP repeat containing 6
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BIRC8
|
baculoviral IAP repeat containing 8
|
|
BIVM
|
basic, immunoglobulin-like variable motif containing
|
|
BLACE
|
B-cell acute lymphoblastic leukemia expressed
|
|
BLCAP
|
bladder cancer associated protein
|
|
BLID
|
BH3-like motif containing, cell death inducer
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BLNK
|
B-cell linker
|
|
BLOC1S1
|
biogenesis of lysosomal organelles complex-1, subunit 1
|
|
BLOC1S2
|
biogenesis of lysosomal organelles complex-1, subunit 2
|
|
BLOC1S3
|
biogenesis of lysosomal organelles complex-1, subunit 3
|
|
BLOC1S6
|
biogenesis of lysosomal organelles complex-1, subunit 6, pallidin
|
|
BMF
|
Bcl2 modifying factor
|
|
BMP1
|
bone morphogenetic protein 1
|
|
BMP10
|
bone morphogenetic protein 10
|
|
BMP15
|
bone morphogenetic protein 15
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP3
|
bone morphogenetic protein 3
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP5
|
bone morphogenetic protein 5
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMP8A
|
bone morphogenetic protein 8a
|
|
BMP8B
|
bone morphogenetic protein 8b
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BNIP1
|
BCL2/adenovirus E1B 19kDa interacting protein 1
|
|
BNIP2
|
BCL2/adenovirus E1B 19kDa interacting protein 2
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BNIP3L
|
BCL2/adenovirus E1B 19kDa interacting protein 3-like
|
|
BNIPL
|
BCL2/adenovirus E1B 19kD interacting protein like
|
|
BOC
|
BOC cell adhesion associated, oncogene regulated
|
|
BOK
|
BCL2-related ovarian killer
|
|
BPI
|
bactericidal/permeability-increasing protein
|
|
BPIFB6
|
BPI fold containing family B, member 6
|
|
BPIFC
|
BPI fold containing family C
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRE
|
brain and reproductive organ-expressed (TNFRSF1A modulator)
|
|
BSG
|
basigin (Ok blood group)
|
|
BST1
|
bone marrow stromal cell antigen 1
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTBD9
|
BTB (POZ) domain containing 9
|
|
BTC
|
betacellulin
|
|
BTG1
|
B-cell translocation gene 1, anti-proliferative
|
|
BTG2
|
BTG family, member 2
|
|
BTG4
|
B-cell translocation gene 4
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BTLA
|
B and T lymphocyte associated
|
|
BTNL2
|
butyrophilin-like 2
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
BVES
|
blood vessel epicardial substance
|
|
BYSL
|
bystin-like
|
|
C1D
|
C1D nuclear receptor corepressor
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QB
|
complement component 1, q subcomponent, B chain
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
C1QBPP1
|
complement component 1, q subcomponent binding protein, pseudogene 1
|
|
C1QC
|
complement component 1, q subcomponent, C chain
|
|
C1QL1
|
complement component 1, q subcomponent-like 1
|
|
C1QL2
|
complement component 1, q subcomponent-like 2
|
|
C1QL3
|
complement component 1, q subcomponent-like 3
|
|
C1QL4
|
complement component 1, q subcomponent-like 4
|
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1
|
|
C1QTNF2
|
C1q and tumor necrosis factor related protein 2
|
|
C1QTNF3
|
C1q and tumor necrosis factor related protein 3
|
|
C1QTNF4
|
C1q and tumor necrosis factor related protein 4
|
|
C1QTNF5
|
C1q and tumor necrosis factor related protein 5
|
|
C1QTNF6
|
C1q and tumor necrosis factor related protein 6
|
|
C1QTNF7
|
C1q and tumor necrosis factor related protein 7
|
|
C1QTNF8
|
C1q and tumor necrosis factor related protein 8
|
|
C1QTNF9
|
C1q and tumor necrosis factor related protein 9
|
|
C1QTNF9B
|
C1q and tumor necrosis factor related protein 9B
|
|
C1R
|
complement component 1, r subcomponent
|
|
C1RL
|
complement component 1, r subcomponent-like
|
|
C1S
|
complement component 1, s subcomponent
|
|
C2
|
complement component 2
|
|
C2CD2
|
C2 calcium-dependent domain containing 2
|
|
C2CD2L
|
C2CD2-like
|
|
C2CD4A
|
C2 calcium-dependent domain containing 4A
|
|
C2CD4B
|
C2 calcium-dependent domain containing 4B
|
|
C2CD4C
|
C2 calcium-dependent domain containing 4C
|
|
C2CD4D
|
C2 calcium-dependent domain containing 4D
|
|
C3
|
complement component 3
|
|
C3AR1
|
complement component 3a receptor 1
|
|
C3ORF38
|
chromosome 3 open reading frame 38
|
|
C3P1
|
complement component 3 precursor pseudogene
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
C4BPA
|
complement component 4 binding protein, alpha
|
|
C4BPB
|
complement component 4 binding protein, beta
|
|
C5
|
complement component 5
|
|
C5AR1
|
complement component 5a receptor 1
|
|
C5AR2
|
complement component 5a receptor 2
|
|
C6
|
complement component 6
|
|
C7
|
complement component 7
|
|
C8A
|
complement component 8, alpha polypeptide
|
|
C8B
|
complement component 8, beta polypeptide
|
|
C8G
|
complement component 8, gamma polypeptide
|
|
C8ORF4
|
chromosome 8 open reading frame 4
|
|
C9
|
complement component 9
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
|
CACNB3
|
calcium channel, voltage-dependent, beta 3 subunit
|
|
CACNB4
|
calcium channel, voltage-dependent, beta 4 subunit
|
|
CADM1
|
cell adhesion molecule 1
|
|
CADM2
|
cell adhesion molecule 2
|
|
CADM3
|
cell adhesion molecule 3
|
|
CADM4
|
cell adhesion molecule 4
|
|
CADPS
|
Ca++-dependent secretion activator
|
|
CADPS2
|
Ca++-dependent secretion activator 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALCOCO2
|
calcium binding and coiled-coil domain 2
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CALR
|
calreticulin
|
|
CALY
|
calcyon neuron-specific vesicular protein
|
|
CAMK1D
|
calcium/calmodulin-dependent protein kinase ID
|
|
CAMK1G
|
calcium/calmodulin-dependent protein kinase IG
|
|
CAMK2D
|
calcium/calmodulin-dependent protein kinase II delta
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CAMLG
|
calcium modulating ligand
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAMSAP3
|
calmodulin regulated spectrin-associated protein family, member 3
|
|
CAP1
|
CAP, adenylate cyclase-associated protein 1 (yeast)
|
|
CAPN10
|
calpain 10
|
|
CARD10
|
caspase recruitment domain family, member 10
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CARD14
|
caspase recruitment domain family, member 14
|
|
CARD16
|
caspase recruitment domain family, member 16
|
|
CARD17
|
caspase recruitment domain family, member 17
|
|
CARD18
|
caspase recruitment domain family, member 18
|
|
CARD6
|
caspase recruitment domain family, member 6
|
|
CARD8
|
caspase recruitment domain family, member 8
|
|
CARD9
|
caspase recruitment domain family, member 9
|
|
CASK
|
calcium/calmodulin-dependent serine protein kinase (MAGUK family)
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP12
|
caspase 12 (gene/pseudogene)
|
|
CASP14
|
caspase 14, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase
|
|
CASP5
|
caspase 5, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP8AP2
|
caspase 8 associated protein 2
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASQ1
|
calsequestrin 1 (fast-twitch, skeletal muscle)
|
|
CASS4
|
Cas scaffolding protein family member 4
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CBLL1
|
Cbl proto-oncogene-like 1, E3 ubiquitin protein ligase
|
|
CBR1
|
carbonyl reductase 1
|
|
CBX4
|
chromobox homolog 4
|
|
CBY1
|
chibby homolog 1 (Drosophila)
|
|
CCAR1
|
cell division cycle and apoptosis regulator 1
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCBE1
|
collagen and calcium binding EGF domains 1
|
|
CCDC85B
|
coiled-coil domain containing 85B
|
|
CCK
|
cholecystokinin
|
|
CCKAR
|
cholecystokinin A receptor
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL13
|
chemokine (C-C motif) ligand 13
|
|
CCL14
|
chemokine (C-C motif) ligand 14
|
|
CCL15
|
chemokine (C-C motif) ligand 15
|
|
CCL16
|
chemokine (C-C motif) ligand 16
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL23
|
chemokine (C-C motif) ligand 23
|
|
CCL24
|
chemokine (C-C motif) ligand 24
|
|
CCL25
|
chemokine (C-C motif) ligand 25
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL27
|
chemokine (C-C motif) ligand 27
|
|
CCL28
|
chemokine (C-C motif) ligand 28
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CCNB1IP1
|
cyclin B1 interacting protein 1, E3 ubiquitin protein ligase
|
|
CCNB2
|
cyclin B2
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNG1
|
cyclin G1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR10
|
chemokine (C-C motif) receptor 10
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR4
|
chemokine (C-C motif) receptor 4
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CCRL2
|
chemokine (C-C motif) receptor-like 2
|
|
CD101
|
CD101 molecule
|
|
CD109
|
CD109 molecule
|
|
CD14
|
CD14 molecule
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD160
|
CD160 molecule
|
|
CD163
|
CD163 molecule
|
|
CD163L1
|
CD163 molecule-like 1
|
|
CD164
|
CD164 molecule, sialomucin
|
|
CD164L2
|
CD164 sialomucin-like 2
|
|
CD177
|
CD177 molecule
|
|
CD180
|
CD180 molecule
|
|
CD19
|
CD19 molecule
|
|
CD1A
|
CD1a molecule
|
|
CD1B
|
CD1b molecule
|
|
CD1C
|
CD1c molecule
|
|
CD1D
|
CD1d molecule
|
|
CD1E
|
CD1e molecule
|
|
CD2
|
CD2 molecule
|
|
CD200
|
CD200 molecule
|
|
CD200R1
|
CD200 receptor 1
|
|
CD200R1L
|
CD200 receptor 1-like
|
|
CD207
|
CD207 molecule, langerin
|
|
CD209
|
CD209 molecule
|
|
CD22
|
CD22 molecule
|
|
CD226
|
CD226 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD247
|
CD247 molecule
|
|
CD248
|
CD248 molecule, endosialin
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD28
|
CD28 molecule
|
|
CD2AP
|
CD2-associated protein
|
|
CD2BP2
|
CD2 (cytoplasmic tail) binding protein 2
|
|
CD300A
|
CD300a molecule
|
|
CD300C
|
CD300c molecule
|
|
CD300E
|
CD300e molecule
|
|
CD300LB
|
CD300 molecule-like family member b
|
|
CD300LD
|
CD300 molecule-like family member d
|
|
CD300LF
|
CD300 molecule-like family member f
|
|
CD300LG
|
CD300 molecule-like family member g
|
|
CD302
|
CD302 molecule
|
|
CD320
|
CD320 molecule
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD37
|
CD37 molecule
|
|
CD38
|
CD38 molecule
|
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex)
|
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex)
|
|
CD3EAP
|
CD3e molecule, epsilon associated protein
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD46P1
|
CD46 molecule, complement regulatory protein pseudogene 1
|
|
CD47
|
CD47 molecule
|
|
CD48
|
CD48 molecule
|
|
CD5
|
CD5 molecule
|
|
CD52
|
CD52 molecule
|
|
CD53
|
CD53 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD58
|
CD58 molecule
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD5L
|
CD5 molecule-like
|
|
CD6
|
CD6 molecule
|
|
CD63
|
CD63 molecule
|
|
CD68
|
CD68 molecule
|
|
CD69
|
CD69 molecule
|
|
CD7
|
CD7 molecule
|
|
CD70
|
CD70 molecule
|
|
CD72
|
CD72 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
|
CD80
|
CD80 molecule
|
|
CD81
|
CD81 molecule
|
|
CD82
|
CD82 molecule
|
|
CD83
|
CD83 molecule
|
|
CD84
|
CD84 molecule
|
|
CD86
|
CD86 molecule
|
|
CD8A
|
CD8a molecule
|
|
CD8B
|
CD8b molecule
|
|
CD9
|
CD9 molecule
|
|
CD93
|
CD93 molecule
|
|
CD96
|
CD96 molecule
|
|
CD99
|
CD99 molecule
|
|
CD99L2
|
CD99 molecule-like 2
|
|
CDC37
|
cell division cycle 37
|
|
CDC42
|
cell division cycle 42
|
|
CDC42SE1
|
CDC42 small effector 1
|
|
CDC42SE2
|
CDC42 small effector 2
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH10
|
cadherin 10, type 2 (T2-cadherin)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH12
|
cadherin 12, type 2 (N-cadherin 2)
|
|
CDH13
|
cadherin 13
|
|
CDH15
|
cadherin 15, type 1, M-cadherin (myotubule)
|
|
CDH16
|
cadherin 16, KSP-cadherin
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
|
CDH18
|
cadherin 18, type 2
|
|
CDH19
|
cadherin 19, type 2
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH20
|
cadherin 20, type 2
|
|
CDH22
|
cadherin 22, type 2
|
|
CDH23
|
cadherin-related 23
|
|
CDH24
|
cadherin 24, type 2
|
|
CDH26
|
cadherin 26
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDH4
|
cadherin 4, type 1, R-cadherin (retinal)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDH6
|
cadherin 6, type 2, K-cadherin (fetal kidney)
|
|
CDH7
|
cadherin 7, type 2
|
|
CDH8
|
cadherin 8, type 2
|
|
CDH9
|
cadherin 9, type 2 (T1-cadherin)
|
|
CDHR1
|
cadherin-related family member 1
|
|
CDHR2
|
cadherin-related family member 2
|
|
CDHR3
|
cadherin-related family member 3
|
|
CDHR4
|
cadherin-related family member 4
|
|
CDHR5
|
cadherin-related family member 5
|
|
CDIP1
|
cell death-inducing p53 target 1
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK11A
|
cyclin-dependent kinase 11A
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
|
|
CDON
|
cell adhesion associated, oncogene regulated
|
|
CDSN
|
corneodesmosin
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM16
|
carcinoembryonic antigen-related cell adhesion molecule 16
|
|
CEACAM18
|
carcinoembryonic antigen-related cell adhesion molecule 18
|
|
CEACAM19
|
carcinoembryonic antigen-related cell adhesion molecule 19
|
|
CEACAM20
|
carcinoembryonic antigen-related cell adhesion molecule 20
|
|
CEACAM21
|
carcinoembryonic antigen-related cell adhesion molecule 21
|
|
CEACAM22P
|
carcinoembryonic antigen-related cell adhesion molecule 22, pseudogene
|
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3
|
|
CEACAM4
|
carcinoembryonic antigen-related cell adhesion molecule 4
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEACAM7
|
carcinoembryonic antigen-related cell adhesion molecule 7
|
|
CEACAM8
|
carcinoembryonic antigen-related cell adhesion molecule 8
|
|
CEACAMP1
|
carcinoembryonic antigen-related cell adhesion molecule pseudogene 1
|
|
CEACAMP10
|
carcinoembryonic antigen-related cell adhesion molecule pseudogene 10
|
|
CEACAMP11
|
carcinoembryonic antigen-related cell adhesion molecule pseudogene 11
|
|
CEACAMP2
|
carcinoembryonic antigen-related cell adhesion molecule pseudogene 2
|
|
CEACAMP3
|
carcinoembryonic antigen-related cell adhesion molecule pseudogene 3
|
|
CEACAMP4
|
carcinoembryonic antigen-related cell adhesion molecule pseudogene 4
|
|
CEACAMP5
|
carcinoembryonic antigen-related cell adhesion molecule pseudogene 5
|
|
CEACAMP6
|
carcinoembryonic antigen-related cell adhesion molecule pseudogene 6
|
|
CEACAMP7
|
carcinoembryonic antigen-related cell adhesion molecule pseudogene 7
|
|
CEACAMP8
|
carcinoembryonic antigen-related cell adhesion molecule pseudogene 8
|
|
CEACAMP9
|
carcinoembryonic antigen-related cell adhesion molecule pseudogene 9
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CEBPG
|
CCAAT/enhancer binding protein (C/EBP), gamma
|
|
CECR1
|
cat eye syndrome chromosome region, candidate 1
|
|
CECR2
|
cat eye syndrome chromosome region, candidate 2
|
|
CELSR1
|
cadherin, EGF LAG seven-pass G-type receptor 1
|
|
CELSR2
|
cadherin, EGF LAG seven-pass G-type receptor 2
|
|
CELSR3
|
cadherin, EGF LAG seven-pass G-type receptor 3
|
|
CENPV
|
centromere protein V
|
|
CER1
|
cerberus 1, DAN family BMP antagonist
|
|
CERCAM
|
cerebral endothelial cell adhesion molecule
|
|
CERK
|
ceramide kinase
|
|
CERKL
|
ceramide kinase-like
|
|
CES1
|
carboxylesterase 1
|
|
CETN2
|
centrin, EF-hand protein, 2
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFB
|
complement factor B
|
|
CFD
|
complement factor D (adipsin)
|
|
CFDP1
|
craniofacial development protein 1
|
|
CFH
|
complement factor H
|
|
CFHR1
|
complement factor H-related 1
|
|
CFHR2
|
complement factor H-related 2
|
|
CFHR3
|
complement factor H-related 3
|
|
CFHR4
|
complement factor H-related 4
|
|
CFHR5
|
complement factor H-related 5
|
|
CFI
|
complement factor I
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFP
|
complement factor properdin
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB5
|
chorionic gonadotropin, beta polypeptide 5
|
|
CGREF1
|
cell growth regulator with EF-hand domain 1
|
|
CHAC1
|
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHD8
|
chromodomain helicase DNA binding protein 8
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHIA
|
chitinase, acidic
|
|
CHL1
|
cell adhesion molecule L1-like
|
|
CHPT1
|
choline phosphotransferase 1
|
|
CHRD
|
chordin
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHST10
|
carbohydrate sulfotransferase 10
|
|
CHST11
|
carbohydrate (chondroitin 4) sulfotransferase 11
|
|
CHST4
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIAPIN1
|
cytokine induced apoptosis inhibitor 1
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
|
CIB2
|
calcium and integrin binding family member 2
|
|
CIB3
|
calcium and integrin binding family member 3
|
|
CIB4
|
calcium and integrin binding family member 4
|
|
CIDEA
|
cell death-inducing DFFA-like effector a
|
|
CIDEB
|
cell death-inducing DFFA-like effector b
|
|
CIDEC
|
cell death-inducing DFFA-like effector c
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CISH
|
cytokine inducible SH2-containing protein
|
|
CITED1
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CKAP2
|
cytoskeleton associated protein 2
|
|
CKLF
|
chemokine-like factor
|
|
CLCA2
|
chloride channel accessory 2
|
|
CLCF1
|
cardiotrophin-like cytokine factor 1
|
|
CLCN5
|
chloride channel, voltage-sensitive 5
|
|
CLDN1
|
claudin 1
|
|
CLDN10
|
claudin 10
|
|
CLDN11
|
claudin 11
|
|
CLDN12
|
claudin 12
|
|
CLDN14
|
claudin 14
|
|
CLDN15
|
claudin 15
|
|
CLDN16
|
claudin 16
|
|
CLDN17
|
claudin 17
|
|
CLDN18
|
claudin 18
|
|
CLDN19
|
claudin 19
|
|
CLDN2
|
claudin 2
|
|
CLDN20
|
claudin 20
|
|
CLDN22
|
claudin 22
|
|
CLDN23
|
claudin 23
|
|
CLDN3
|
claudin 3
|
|
CLDN4
|
claudin 4
|
|
CLDN5
|
claudin 5
|
|
CLDN6
|
claudin 6
|
|
CLDN7
|
claudin 7
|
|
CLDN8
|
claudin 8
|
|
CLDN9
|
claudin 9
|
|
CLEC10A
|
C-type lectin domain family 10, member A
|
|
CLEC4A
|
C-type lectin domain family 4, member A
|
|
CLEC4F
|
C-type lectin domain family 4, member F
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
|
CLEC5A
|
C-type lectin domain family 5, member A
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
CLINT1
|
clathrin interactor 1
|
|
CLLU1OS
|
chronic lymphocytic leukemia up-regulated 1 opposite strand
|
|
CLN3
|
ceroid-lipofuscinosis, neuronal 3
|
|
CLN8
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
|
|
CLNK
|
cytokine-dependent hematopoietic cell linker
|
|
CLPTM1
|
cleft lip and palate associated transmembrane protein 1
|
|
CLPTM1L
|
CLPTM1-like
|
|
CLSTN1
|
calsyntenin 1
|
|
CLSTN2
|
calsyntenin 2
|
|
CLSTN3
|
calsyntenin 3
|
|
CLTA
|
clathrin, light chain A
|
|
CLTC
|
clathrin, heavy chain (Hc)
|
|
CLTCL1
|
clathrin, heavy chain-like 1
|
|
CLU
|
clusterin
|
|
CMA1
|
chymase 1, mast cell
|
|
CMAS
|
cytidine monophosphate N-acetylneuraminic acid synthetase
|
|
CMC4
|
C-x(9)-C motif containing 4
|
|
CMKLR1
|
chemerin chemokine-like receptor 1
|
|
CMTM1
|
CKLF-like MARVEL transmembrane domain containing 1
|
|
CMTM2
|
CKLF-like MARVEL transmembrane domain containing 2
|
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3
|
|
CMTM4
|
CKLF-like MARVEL transmembrane domain containing 4
|
|
CMTM5
|
CKLF-like MARVEL transmembrane domain containing 5
|
|
CMTM6
|
CKLF-like MARVEL transmembrane domain containing 6
|
|
CMTM7
|
CKLF-like MARVEL transmembrane domain containing 7
|
|
CMTM8
|
CKLF-like MARVEL transmembrane domain containing 8
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTF
|
ciliary neurotrophic factor
|
|
CNTFR
|
ciliary neurotrophic factor receptor
|
|
CNTN1
|
contactin 1
|
|
CNTN2
|
contactin 2 (axonal)
|
|
CNTN3
|
contactin 3 (plasmacytoma associated)
|
|
CNTN4
|
contactin 4
|
|
CNTN5
|
contactin 5
|
|
CNTN6
|
contactin 6
|
|
CNTNAP1
|
contactin associated protein 1
|
|
CNTNAP2
|
contactin associated protein-like 2
|
|
CNTNAP3
|
contactin associated protein-like 3
|
|
CNTNAP4
|
contactin associated protein-like 4
|
|
CNTNAP5
|
contactin associated protein-like 5
|
|
CNTROB
|
centrobin, centrosomal BRCA2 interacting protein
|
|
COL11A1
|
collagen, type XI, alpha 1
|
|
COL11A2
|
collagen, type XI, alpha 2
|
|
COL12A1
|
collagen, type XII, alpha 1
|
|
COL13A1
|
collagen, type XIII, alpha 1
|
|
COL14A1
|
collagen, type XIV, alpha 1
|
|
COL15A1
|
collagen, type XV, alpha 1
|
|
COL16A1
|
collagen, type XVI, alpha 1
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL19A1
|
collagen, type XIX, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL20A1
|
collagen, type XX, alpha 1
|
|
COL21A1
|
collagen, type XXI, alpha 1
|
|
COL24A1
|
collagen, type XXIV, alpha 1
|
|
COL27A1
|
collagen, type XXVII, alpha 1
|
|
COL28A1
|
collagen, type XXVIII, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL4A6
|
collagen, type IV, alpha 6
|
|
COL5A1
|
collagen, type V, alpha 1
|
|
COL5A3
|
collagen, type V, alpha 3
|
|
COL6A1
|
collagen, type VI, alpha 1
|
|
COL6A2
|
collagen, type VI, alpha 2
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
COL6A5
|
collagen, type VI, alpha 5
|
|
COL6A6
|
collagen, type VI, alpha 6
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
COL8A1
|
collagen, type VIII, alpha 1
|
|
COL8A2
|
collagen, type VIII, alpha 2
|
|
COL9A1
|
collagen, type IX, alpha 1
|
|
COLEC12
|
collectin sub-family member 12
|
|
COLGALT1
|
collagen beta(1-O)galactosyltransferase 1
|
|
COLGALT2
|
collagen beta(1-O)galactosyltransferase 2
|
|
COMMD7
|
COMM domain containing 7
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
COPG1
|
coatomer protein complex, subunit gamma 1
|
|
COPG2
|
coatomer protein complex, subunit gamma 2
|
|
CORO1A
|
coronin, actin binding protein, 1A
|
|
CORO1C
|
coronin, actin binding protein, 1C
|
|
COTL1
|
coactosin-like F-actin binding protein 1
|
|
COTL1P2
|
coactosin-like F-actin binding protein 1 pseudogene 2
|
|
CPA3
|
carboxypeptidase A3 (mast cell)
|
|
CPLX1
|
complexin 1
|
|
CPLX2
|
complexin 2
|
|
CPLX3
|
complexin 3
|
|
CPLX4
|
complexin 4
|
|
CPS1
|
carbamoyl-phosphate synthase 1, mitochondrial
|
|
CPXM1
|
carboxypeptidase X (M14 family), member 1
|
|
CPXM2
|
carboxypeptidase X (M14 family), member 2
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CR1L
|
complement component (3b/4b) receptor 1-like
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CRADD
|
CASP2 and RIPK1 domain containing adaptor with death domain
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREB3
|
cAMP responsive element binding protein 3
|
|
CRH
|
corticotropin releasing hormone
|
|
CRIP3
|
cysteine-rich protein 3
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRLF1
|
cytokine receptor-like factor 1
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRLF3
|
cytokine receptor-like factor 3
|
|
CRNN
|
cornulin
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTAM
|
cytotoxic and regulatory T cell molecule
|
|
CRYAA
|
crystallin, alpha A
|
|
CRYAB
|
crystallin, alpha B
|
|
CSE1L
|
CSE1 chromosome segregation 1-like (yeast)
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF2RA
|
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CSRNP1
|
cysteine-serine-rich nuclear protein 1
|
|
CSRNP2
|
cysteine-serine-rich nuclear protein 2
|
|
CSRNP3
|
cysteine-serine-rich nuclear protein 3
|
|
CSTB
|
cystatin B (stefin B)
|
|
CSTL1
|
cystatin-like 1
|
|
CTAGE1
|
cutaneous T-cell lymphoma-associated antigen 1
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTBP2
|
C-terminal binding protein 2
|
|
CTF1
|
cardiotrophin 1
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNA2
|
catenin (cadherin-associated protein), alpha 2
|
|
CTNNA3
|
catenin (cadherin-associated protein), alpha 3
|
|
CTNNAL1
|
catenin (cadherin-associated protein), alpha-like 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTNNBL1
|
catenin, beta like 1
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTNND2
|
catenin (cadherin-associated protein), delta 2
|
|
CTSA
|
cathepsin A
|
|
CTSB
|
cathepsin B
|
|
CTSC
|
cathepsin C
|
|
CTSD
|
cathepsin D
|
|
CTSE
|
cathepsin E
|
|
CTSF
|
cathepsin F
|
|
CTSG
|
cathepsin G
|
|
CTSH
|
cathepsin H
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CTSL3P
|
cathepsin L family member 3, pseudogene
|
|
CTSO
|
cathepsin O
|
|
CTSS
|
cathepsin S
|
|
CTSV
|
cathepsin V
|
|
CTSW
|
cathepsin W
|
|
CTSZ
|
cathepsin Z
|
|
CUBN
|
cubilin (intrinsic factor-cobalamin receptor)
|
|
CUL1
|
cullin 1
|
|
CUL2
|
cullin 2
|
|
CUL3
|
cullin 3
|
|
CUL4A
|
cullin 4A
|
|
CUL5
|
cullin 5
|
|
CUTA
|
cutA divalent cation tolerance homolog (E. coli)
|
|
CUZD1
|
CUB and zona pellucida-like domains 1
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL17
|
chemokine (C-X-C motif) ligand 17
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL3
|
chemokine (C-X-C motif) ligand 3
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL6
|
chemokine (C-X-C motif) ligand 6
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR2P1
|
chemokine (C-X-C motif) receptor 2 pseudogene 1
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYCS
|
cytochrome c, somatic
|
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1
|
|
CYP26C1
|
cytochrome P450, family 26, subfamily C, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP4F8
|
cytochrome P450, family 4, subfamily F, polypeptide 8
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
CYTH1
|
cytohesin 1
|
|
CYTH2
|
cytohesin 2
|
|
CYTH3
|
cytohesin 3
|
|
CYTIP
|
cytohesin 1 interacting protein
|
|
CYTL1
|
cytokine-like 1
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DAD1
|
defender against cell death 1
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAND5
|
DAN domain family member 5, BMP antagonist
|
|
DAP
|
death-associated protein
|
|
DAP3
|
death associated protein 3
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAPK2
|
death-associated protein kinase 2
|
|
DAPK3
|
death-associated protein kinase 3
|
|
DAPL1
|
death associated protein-like 1
|
|
DAXX
|
death-domain associated protein
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DBNL
|
drebrin-like
|
|
DCBLD1
|
discoidin, CUB and LCCL domain containing 1
|
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCDC2
|
doublecortin domain containing 2
|
|
DCHS1
|
dachsous cadherin-related 1
|
|
DCHS2
|
dachsous cadherin-related 2
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DCN
|
decorin
|
|
DCTN3
|
dynactin 3 (p22)
|
|
DCUN1D3
|
DCN1, defective in cullin neddylation 1, domain containing 3
|
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2
|
|
DDIAS
|
DNA damage-induced apoptosis suppressor
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DDOST
|
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic)
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DDR2
|
discoidin domain receptor tyrosine kinase 2
|
|
DDX20
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 20
|
|
DDX39B
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B
|
|
DDX41
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 41
|
|
DDX42
|
DEAD (Asp-Glu-Ala-Asp) box helicase 42
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEDD
|
death effector domain containing
|
|
DEDD2
|
death effector domain containing 2
|
|
DEFA10P
|
defensin, alpha 10 pseudogene
|
|
DEFA11P
|
defensin, alpha 11 pseudogene
|
|
DEFA1B
|
defensin, alpha 1B
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DEFA4
|
defensin, alpha 4, corticostatin
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DEFA6
|
defensin, alpha 6, Paneth cell-specific
|
|
DEFA7P
|
defensin, alpha 7 pseudogene
|
|
DEFA8P
|
defensin, alpha 8 pseudogene
|
|
DEFA9P
|
defensin, alpha 9 pseudogene
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB104B
|
defensin, beta 104B
|
|
DEFB105A
|
defensin, beta 105A
|
|
DEFB106A
|
defensin, beta 106A
|
|
DEFB107A
|
defensin, beta 107A
|
|
DEFB108B
|
defensin, beta 108B
|
|
DEFB108P1
|
defensin, beta 108, pseudogene 1
|
|
DEFB108P2
|
defensin, beta 108, pseudogene 2
|
|
DEFB108P3
|
defensin, beta 108, pseudogene 3
|
|
DEFB108P4
|
defensin, beta 108, pseudogene 4
|
|
DEFB109P1
|
defensin, beta 109, pseudogene 1
|
|
DEFB109P1B
|
defensin, beta 109, pseudogene 1B
|
|
DEFB109P2
|
defensin, beta 109, pseudogene 2
|
|
DEFB109P3
|
defensin, beta 109, pseudogene 3
|
|
DEFB110
|
defensin, beta 110
|
|
DEFB112
|
defensin, beta 112
|
|
DEFB113
|
defensin, beta 113
|
|
DEFB114
|
defensin, beta 114
|
|
DEFB115
|
defensin, beta 115
|
|
DEFB116
|
defensin, beta 116
|
|
DEFB117
|
defensin, beta 117 (pseudogene)
|
|
DEFB118
|
defensin, beta 118
|
|
DEFB119
|
defensin, beta 119
|
|
DEFB121
|
defensin, beta 121
|
|
DEFB122
|
defensin, beta 122 (pseudogene)
|
|
DEFB123
|
defensin, beta 123
|
|
DEFB124
|
defensin, beta 124
|
|
DEFB125
|
defensin, beta 125
|
|
DEFB126
|
defensin, beta 126
|
|
DEFB127
|
defensin, beta 127
|
|
DEFB128
|
defensin, beta 128
|
|
DEFB129
|
defensin, beta 129
|
|
DEFB130
|
defensin, beta 130
|
|
DEFB131
|
defensin, beta 131
|
|
DEFB132
|
defensin, beta 132
|
|
DEFB133
|
defensin, beta 133
|
|
DEFB134
|
defensin, beta 134
|
|
DEFB135
|
defensin, beta 135
|
|
DEFB136
|
defensin, beta 136
|
|
DEFB4B
|
defensin, beta 4B
|
|
DEFT1P
|
defensin, theta 1 pseudogene
|
|
DEFT1P2
|
defensin, theta 1 pseudogene 2
|
|
DENND1A
|
DENN/MADD domain containing 1A
|
|
DEPTOR
|
DEP domain containing MTOR-interacting protein
|
|
DERL1
|
derlin 1
|
|
DFFA
|
DNA fragmentation factor, 45kDa, alpha polypeptide
|
|
DFFB
|
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)
|
|
DGCR14
|
DiGeorge syndrome critical region gene 14
|
|
DGCR2
|
DiGeorge syndrome critical region gene 2
|
|
DGCR5
|
DiGeorge syndrome critical region gene 5 (non-protein coding)
|
|
DGCR6
|
DiGeorge syndrome critical region gene 6
|
|
DGCR6L
|
DiGeorge syndrome critical region gene 6-like
|
|
DGCR8
|
DGCR8 microprocessor complex subunit
|
|
DGKA
|
diacylglycerol kinase, alpha 80kDa
|
|
DGKB
|
diacylglycerol kinase, beta 90kDa
|
|
DGKD
|
diacylglycerol kinase, delta 130kDa
|
|
DGKE
|
diacylglycerol kinase, epsilon 64kDa
|
|
DGKG
|
diacylglycerol kinase, gamma 90kDa
|
|
DGKH
|
diacylglycerol kinase, eta
|
|
DGKI
|
diacylglycerol kinase, iota
|
|
DGKK
|
diacylglycerol kinase, kappa
|
|
DGKQ
|
diacylglycerol kinase, theta 110kDa
|
|
DGKZ
|
diacylglycerol kinase, zeta
|
|
DHCR24
|
24-dehydrocholesterol reductase
|
|
DHODH
|
dihydroorotate dehydrogenase (quinone)
|
|
DHRS2
|
dehydrogenase/reductase (SDR family) member 2
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DIAPH2
|
diaphanous-related formin 2
|
|
DIDO1
|
death inducer-obliterator 1
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLEU1
|
deleted in lymphocytic leukemia 1 (non-protein coding)
|
|
DLEU2
|
deleted in lymphocytic leukemia 2 (non-protein coding)
|
|
DLEU2L
|
deleted in lymphocytic leukemia 2-like
|
|
DLEU7
|
deleted in lymphocytic leukemia, 7
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DLG5
|
discs, large homolog 5 (Drosophila)
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DLX1
|
distal-less homeobox 1
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DMP1
|
dentin matrix acidic phosphoprotein 1
|
|
DNAJA3
|
DnaJ (Hsp40) homolog, subfamily A, member 3
|
|
DNAJB13
|
DnaJ (Hsp40) homolog, subfamily B, member 13
|
|
DNAJB2
|
DnaJ (Hsp40) homolog, subfamily B, member 2
|
|
DNAJB6
|
DnaJ (Hsp40) homolog, subfamily B, member 6
|
|
DNAJC5
|
DnaJ (Hsp40) homolog, subfamily C, member 5
|
|
DNASE1
|
deoxyribonuclease I
|
|
DNASE1L3
|
deoxyribonuclease I-like 3
|
|
DNASE2
|
deoxyribonuclease II, lysosomal
|
|
DNER
|
delta/notch-like EGF repeat containing
|
|
DNM1
|
dynamin 1
|
|
DNM1L
|
dynamin 1-like
|
|
DNM2
|
dynamin 2
|
|
DNM3
|
dynamin 3
|
|
DOC2A
|
double C2-like domains, alpha
|
|
DOC2B
|
double C2-like domains, beta
|
|
DOCK1
|
dedicator of cytokinesis 1
|
|
DOCK10
|
dedicator of cytokinesis 10
|
|
DOCK11
|
dedicator of cytokinesis 11
|
|
DOCK2
|
dedicator of cytokinesis 2
|
|
DOCK3
|
dedicator of cytokinesis 3
|
|
DOCK4
|
dedicator of cytokinesis 4
|
|
DOCK5
|
dedicator of cytokinesis 5
|
|
DOCK6
|
dedicator of cytokinesis 6
|
|
DOCK7
|
dedicator of cytokinesis 7
|
|
DOCK8
|
dedicator of cytokinesis 8
|
|
DOCK9
|
dedicator of cytokinesis 9
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DPF1
|
D4, zinc and double PHD fingers family 1
|
|
DPF2
|
D4, zinc and double PHD fingers family 2
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPT
|
dermatopontin
|
|
DRAM1
|
DNA-damage regulated autophagy modulator 1
|
|
DRAM2
|
DNA-damage regulated autophagy modulator 2
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DRD5
|
dopamine receptor D5
|
|
DSC1
|
desmocollin 1
|
|
DSC2
|
desmocollin 2
|
|
DSC3
|
desmocollin 3
|
|
DSCAM
|
Down syndrome cell adhesion molecule
|
|
DSCAML1
|
Down syndrome cell adhesion molecule like 1
|
|
DSG1
|
desmoglein 1
|
|
DSG2
|
desmoglein 2
|
|
DSG3
|
desmoglein 3
|
|
DSG4
|
desmoglein 4
|
|
DSP
|
desmoplakin
|
|
DST
|
dystonin
|
|
DUOX1
|
dual oxidase 1
|
|
DUOX2
|
dual oxidase 2
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP22
|
dual specificity phosphatase 22
|
|
DUSP3
|
dual specificity phosphatase 3
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DYNLT1
|
dynein, light chain, Tctex-type 1
|
|
DYRK2
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F2
|
E2F transcription factor 2
|
|
EAF2
|
ELL associated factor 2
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EBF1
|
early B-cell factor 1
|
|
EBF2
|
early B-cell factor 2
|
|
EBF3
|
early B-cell factor 3
|
|
EBF4
|
early B-cell factor 4
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
ECE1
|
endothelin converting enzyme 1
|
|
ECM2
|
extracellular matrix protein 2, female organ and adipocyte specific
|
|
ECSCR
|
endothelial cell surface expressed chemotaxis and apoptosis regulator
|
|
ECT2
|
epithelial cell transforming 2
|
|
EDA
|
ectodysplasin A
|
|
EDA2R
|
ectodysplasin A2 receptor
|
|
EDAR
|
ectodysplasin A receptor
|
|
EDIL3
|
EGF-like repeats and discoidin I-like domains 3
|
|
EDN1
|
endothelin 1
|
|
EDN2
|
endothelin 2
|
|
EDN3
|
endothelin 3
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EEF1E1
|
eukaryotic translation elongation factor 1 epsilon 1
|
|
EFCAB13
|
EF-hand calcium binding domain 13
|
|
EFNB1
|
ephrin-B1
|
|
EFNB2
|
ephrin-B2
|
|
EFS
|
embryonal Fyn-associated substrate
|
|
EGF
|
epidermal growth factor
|
|
EGFL6
|
EGF-like-domain, multiple 6
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
EGOT
|
eosinophil granule ontogeny transcript (non-protein coding)
|
|
EGR1
|
early growth response 1
|
|
EHD1
|
EH-domain containing 1
|
|
EHD2
|
EH-domain containing 2
|
|
EHD4
|
EH-domain containing 4
|
|
EI24
|
etoposide induced 2.4
|
|
EID2
|
EP300 interacting inhibitor of differentiation 2
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF5A
|
eukaryotic translation initiation factor 5A
|
|
EIF5AL1
|
eukaryotic translation initiation factor 5A-like 1
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELF1
|
E74-like factor 1 (ets domain transcription factor)
|
|
ELF4
|
E74-like factor 4 (ets domain transcription factor)
|
|
ELMO1
|
engulfment and cell motility 1
|
|
ELMO2
|
engulfment and cell motility 2
|
|
ELMO3
|
engulfment and cell motility 3
|
|
ELMOD1
|
ELMO/CED-12 domain containing 1
|
|
ELMOD2
|
ELMO/CED-12 domain containing 2
|
|
ELMOD3
|
ELMO/CED-12 domain containing 3
|
|
EMB
|
embigin
|
|
EMC4
|
ER membrane protein complex subunit 4
|
|
EMILIN1
|
elastin microfibril interfacer 1
|
|
EMILIN2
|
elastin microfibril interfacer 2
|
|
ENDOG
|
endonuclease G
|
|
ENG
|
endoglin
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
ENTPD2
|
ectonucleoside triphosphate diphosphohydrolase 2
|
|
EOMES
|
eomesodermin
|
|
EP300
|
E1A binding protein p300
|
|
EPB41L5
|
erythrocyte membrane protein band 4.1 like 5
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA2
|
EPH receptor A2
|
|
EPHA3
|
EPH receptor A3
|
|
EPHA7
|
EPH receptor A7
|
|
EPN1
|
epsin 1
|
|
EPN2
|
epsin 2
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
EPS15L1
|
epidermal growth factor receptor pathway substrate 15-like 1
|
|
EPX
|
eosinophil peroxidase
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB2IP
|
erbb2 interacting protein
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERC1
|
ELKS/RAB6-interacting/CAST family member 1
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERCC6L
|
excision repair cross-complementation group 6-like
|
|
ERCC8
|
excision repair cross-complementation group 8
|
|
EREG
|
epiregulin
|
|
ERMAP
|
erythroblast membrane-associated protein (Scianna blood group)
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ERN2
|
endoplasmic reticulum to nucleus signaling 2
|
|
ERO1L
|
ERO1-like (S. cerevisiae)
|
|
ESAM
|
endothelial cell adhesion molecule
|
|
ESPL1
|
extra spindle pole bodies homolog 1 (S. cerevisiae)
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EVA1A
|
eva-1 homolog A (C. elegans)
|
|
EXO1
|
exonuclease 1
|
|
EXOC1
|
exocyst complex component 1
|
|
EXOC2
|
exocyst complex component 2
|
|
EXOC3
|
exocyst complex component 3
|
|
EXOC3L1
|
exocyst complex component 3-like 1
|
|
EXOC4
|
exocyst complex component 4
|
|
EXOC5
|
exocyst complex component 5
|
|
EXOC6
|
exocyst complex component 6
|
|
EXOC6B
|
exocyst complex component 6B
|
|
EXOC7
|
exocyst complex component 7
|
|
EXOC8
|
exocyst complex component 8
|
|
EXTL1
|
exostosin-like glycosyltransferase 1
|
|
EYA1
|
EYA transcriptional coactivator and phosphatase 1
|
|
EYA2
|
EYA transcriptional coactivator and phosphatase 2
|
|
EZR
|
ezrin
|
|
F11R
|
F11 receptor
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAF1
|
Fas (TNFRSF6) associated factor 1
|
|
FAF2
|
Fas associated factor family member 2
|
|
FAIM
|
Fas apoptotic inhibitory molecule
|
|
FAIM2
|
Fas apoptotic inhibitory molecule 2
|
|
FAM188A
|
family with sequence similarity 188, member A
|
|
FAM19A1
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A1
|
|
FAM19A2
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A2
|
|
FAM19A3
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A3
|
|
FAM19A4
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A4
|
|
FAM19A5
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5
|
|
FAM215A
|
family with sequence similarity 215, member A (non-protein coding)
|
|
FAM3B
|
family with sequence similarity 3, member B
|
|
FAM3C
|
family with sequence similarity 3, member C
|
|
FAM3D
|
family with sequence similarity 3, member D
|
|
FAN1
|
FANCD2/FANCI-associated nuclease 1
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCB
|
Fanconi anemia, complementation group B
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCE
|
Fanconi anemia, complementation group E
|
|
FANCF
|
Fanconi anemia, complementation group F
|
|
FANCG
|
Fanconi anemia, complementation group G
|
|
FANCI
|
Fanconi anemia, complementation group I
|
|
FANCL
|
Fanconi anemia, complementation group L
|
|
FANCM
|
Fanconi anemia, complementation group M
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASTK
|
Fas-activated serine/threonine kinase
|
|
FASTKD1
|
FAST kinase domains 1
|
|
FASTKD2
|
FAST kinase domains 2
|
|
FASTKD3
|
FAST kinase domains 3
|
|
FASTKD5
|
FAST kinase domains 5
|
|
FAT1
|
FAT atypical cadherin 1
|
|
FAT2
|
FAT atypical cadherin 2
|
|
FAT3
|
FAT atypical cadherin 3
|
|
FAT4
|
FAT atypical cadherin 4
|
|
FBF1
|
Fas (TNFRSF6) binding factor 1
|
|
FBLIM1
|
filamin binding LIM protein 1
|
|
FBLN5
|
fibulin 5
|
|
FBLN7
|
fibulin 7
|
|
FCAMR
|
Fc receptor, IgA, IgM, high affinity
|
|
FCAR
|
Fc fragment of IgA receptor
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCF1
|
FCF1 rRNA-processing protein
|
|
FCGBP
|
Fc fragment of IgG binding protein
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR1B
|
Fc fragment of IgG, high affinity Ib, receptor (CD64)
|
|
FCGR1C
|
Fc fragment of IgG, high affinity Ic, receptor (CD64), pseudogene
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR2C
|
Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FCHO1
|
FCH domain only 1
|
|
FCHO2
|
FCH domain only 2
|
|
FCHSD1
|
FCH and double SH3 domains 1
|
|
FCHSD2
|
FCH and double SH3 domains 2
|
|
FCMR
|
Fc fragment of IgM receptor
|
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3
|
|
FCRL1
|
Fc receptor-like 1
|
|
FCRL2
|
Fc receptor-like 2
|
|
FCRL3
|
Fc receptor-like 3
|
|
FCRL4
|
Fc receptor-like 4
|
|
FCRL5
|
Fc receptor-like 5
|
|
FCRL6
|
Fc receptor-like 6
|
|
FCRLA
|
Fc receptor-like A
|
|
FCRLB
|
Fc receptor-like B
|
|
FEM1B
|
fem-1 homolog b (C. elegans)
|
|
FER
|
fer (fps/fes related) tyrosine kinase
|
|
FERMT1
|
fermitin family member 1
|
|
FERMT2
|
fermitin family member 2
|
|
FERMT3
|
fermitin family member 3
|
|
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I)
|
|
FEZ2
|
fasciculation and elongation protein zeta 2 (zygin II)
|
|
FEZF2
|
FEZ family zinc finger 2
|
|
FGA
|
fibrinogen alpha chain
|
|
FGB
|
fibrinogen beta chain
|
|
FGD1
|
FYVE, RhoGEF and PH domain containing 1
|
|
FGD2
|
FYVE, RhoGEF and PH domain containing 2
|
|
FGD3
|
FYVE, RhoGEF and PH domain containing 3
|
|
FGD4
|
FYVE, RhoGEF and PH domain containing 4
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF19
|
fibroblast growth factor 19
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF3
|
fibroblast growth factor 3
|
|
FGF4
|
fibroblast growth factor 4
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGG
|
fibrinogen gamma chain
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FIS1
|
fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae)
|
|
FKBP10
|
FK506 binding protein 10, 65 kDa
|
|
FKBP11
|
FK506 binding protein 11, 19 kDa
|
|
FKBP14
|
FK506 binding protein 14, 22 kDa
|
|
FKBP15
|
FK506 binding protein 15, 133kDa
|
|
FKBP1A
|
FK506 binding protein 1A, 12kDa
|
|
FKBP1AP3
|
FK506 binding protein 1A, 12kDa pseudogene 3
|
|
FKBP1B
|
FK506 binding protein 1B, 12.6 kDa
|
|
FKBP1C
|
FK506 binding protein 1C
|
|
FKBP2
|
FK506 binding protein 2, 13kDa
|
|
FKBP3
|
FK506 binding protein 3, 25kDa
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FKBP5
|
FK506 binding protein 5
|
|
FKBP6
|
FK506 binding protein 6, 36kDa
|
|
FKBP7
|
FK506 binding protein 7
|
|
FKBP8
|
FK506 binding protein 8, 38kDa
|
|
FKBP9
|
FK506 binding protein 9, 63 kDa
|
|
FKBP9P1
|
FK506 binding protein 9 pseudogene 1
|
|
FKBPL
|
FK506 binding protein like
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLNA
|
filamin A, alpha
|
|
FLOT2
|
flotillin 2
|
|
FLRT1
|
fibronectin leucine rich transmembrane protein 1
|
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2
|
|
FLRT3
|
fibronectin leucine rich transmembrane protein 3
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FLVCR1
|
feline leukemia virus subgroup C cellular receptor 1
|
|
FMO1
|
flavin containing monooxygenase 1
|
|
FMOD
|
fibromodulin
|
|
FN1
|
fibronectin 1
|
|
FNBP1
|
formin binding protein 1
|
|
FNBP1L
|
formin binding protein 1-like
|
|
FNDC3A
|
fibronectin type III domain containing 3A
|
|
FNDC3B
|
fibronectin type III domain containing 3B
|
|
FNTA
|
farnesyltransferase, CAAX box, alpha
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXA2
|
forkhead box A2
|
|
FOXC1
|
forkhead box C1
|
|
FOXC2
|
forkhead box C2
|
|
FOXD1
|
forkhead box D1
|
|
FOXD2
|
forkhead box D2
|
|
FOXD3
|
forkhead box D3
|
|
FOXD4
|
forkhead box D4
|
|
FOXD4L1
|
forkhead box D4-like 1
|
|
FOXD4L3
|
forkhead box D4-like 3
|
|
FOXD4L5
|
forkhead box D4-like 5
|
|
FOXD4L6
|
forkhead box D4-like 6
|
|
FOXH1
|
forkhead box H1
|
|
FOXJ1
|
forkhead box J1
|
|
FOXL2
|
forkhead box L2
|
|
FOXN1
|
forkhead box N1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP1
|
forkhead box P1
|
|
FOXP3
|
forkhead box P3
|
|
FOXQ1
|
forkhead box Q1
|
|
FOXS1
|
forkhead box S1
|
|
FPR1
|
formyl peptide receptor 1
|
|
FPR2
|
formyl peptide receptor 2
|
|
FPR3
|
formyl peptide receptor 3
|
|
FRAT1
|
frequently rearranged in advanced T-cell lymphomas 1
|
|
FRAT2
|
frequently rearranged in advanced T-cell lymphomas 2
|
|
FREM1
|
FRAS1 related extracellular matrix 1
|
|
FREM2
|
FRAS1 related extracellular matrix protein 2
|
|
FREM3
|
FRAS1 related extracellular matrix 3
|
|
FRK
|
fyn-related Src family tyrosine kinase
|
|
FRZB
|
frizzled-related protein
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FSCN2
|
fascin actin-bundling protein 2, retinal
|
|
FSCN3
|
fascin actin-bundling protein 3, testicular
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FSTL1
|
follistatin-like 1
|
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
FTO
|
fat mass and obesity associated
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FUT1
|
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FUT8
|
fucosyltransferase 8 (alpha (1,6) fucosyltransferase)
|
|
FXN
|
frataxin
|
|
FXR1
|
fragile X mental retardation, autosomal homolog 1
|
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
|
FYB
|
FYN binding protein
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
FZD4
|
frizzled class receptor 4
|
|
FZD5
|
frizzled class receptor 5
|
|
G2E3
|
G2/M-phase specific E3 ubiquitin protein ligase
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GAB4
|
GRB2-associated binding protein family, member 4
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GADD45G
|
growth arrest and DNA-damage-inducible, gamma
|
|
GAGE1
|
G antigen 1
|
|
GAGE2D
|
G antigen 2D
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALNT16
|
polypeptide N-acetylgalactosaminyltransferase 16
|
|
GALNT2
|
polypeptide N-acetylgalactosaminyltransferase 2
|
|
GAP43
|
growth associated protein 43
|
|
GAPT
|
GRB2-binding adaptor protein, transmembrane
|
|
GAPVD1
|
GTPase activating protein and VPS9 domains 1
|
|
GAS1
|
growth arrest-specific 1
|
|
GAS2
|
growth arrest-specific 2
|
|
GATA2
|
GATA binding protein 2
|
|
GATA6
|
GATA binding protein 6
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GBP2
|
guanylate binding protein 2, interferon-inducible
|
|
GBX2
|
gastrulation brain homeobox 2
|
|
GCGR
|
glucagon receptor
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCLC
|
glutamate-cysteine ligase, catalytic subunit
|
|
GCLM
|
glutamate-cysteine ligase, modifier subunit
|
|
GCM2
|
glial cells missing homolog 2 (Drosophila)
|
|
GCNT2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)
|
|
GCSAM
|
germinal center-associated, signaling and motility
|
|
GDF1
|
growth differentiation factor 1
|
|
GDF10
|
growth differentiation factor 10
|
|
GDF11
|
growth differentiation factor 11
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF2
|
growth differentiation factor 2
|
|
GDF3
|
growth differentiation factor 3
|
|
GDF5
|
growth differentiation factor 5
|
|
GDF6
|
growth differentiation factor 6
|
|
GDF7
|
growth differentiation factor 7
|
|
GDF9
|
growth differentiation factor 9
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GFRAL
|
GDNF family receptor alpha like
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GIMAP5
|
GTPase, IMAP family member 5
|
|
GIPC1
|
GIPC PDZ domain containing family, member 1
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLMN
|
glomulin, FKBP associated protein
|
|
GLO1
|
glyoxalase I
|
|
GLRX2
|
glutaredoxin 2
|
|
GLRX3
|
glutaredoxin 3
|
|
GLYATL1
|
glycine-N-acyltransferase-like 1
|
|
GLYATL1P4
|
glycine-N-acyltransferase-like 1 pseudogene 4
|
|
GLYCAM1
|
glycosylation dependent cell adhesion molecule 1 (pseudogene)
|
|
GMDS
|
GDP-mannose 4,6-dehydratase
|
|
GML
|
glycosylphosphatidylinositol anchored molecule like
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GNAI2
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2
|
|
GNAO1
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12
|
|
GNL1
|
guanine nucleotide binding protein-like 1
|
|
GNLY
|
granulysin
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP1BB
|
glycoprotein Ib (platelet), beta polypeptide
|
|
GP5
|
glycoprotein V (platelet)
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GP9
|
glycoprotein IX (platelet)
|
|
GPAM
|
glycerol-3-phosphate acyltransferase, mitochondrial
|
|
GPANK1
|
G patch domain and ankyrin repeats 1
|
|
GPC3
|
glypican 3
|
|
GPI
|
glucose-6-phosphate isomerase
|
|
GPNMB
|
glycoprotein (transmembrane) nmb
|
|
GPR17
|
G protein-coupled receptor 17
|
|
GPR183
|
G protein-coupled receptor 183
|
|
GPR65
|
G protein-coupled receptor 65
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRAMD4
|
GRAM domain containing 4
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GREM2
|
gremlin 2, DAN family BMP antagonist
|
|
GRID2
|
glutamate receptor, ionotropic, delta 2
|
|
GRIK2
|
glutamate receptor, ionotropic, kainate 2
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRK1
|
G protein-coupled receptor kinase 1
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
GRN
|
granulin
|
|
GSDMA
|
gasdermin A
|
|
GSG2
|
germ cell associated 2 (haspin)
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GSPT1
|
G1 to S phase transition 1
|
|
GSS
|
glutathione synthetase
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GTPBP4
|
GTP binding protein 4
|
|
GULP1
|
GULP, engulfment adaptor PTB domain containing 1
|
|
GVINP1
|
GTPase, very large interferon inducible pseudogene 1
|
|
GYLTL1B
|
glycosyltransferase-like 1B
|
|
GYPA
|
glycophorin A (MNS blood group)
|
|
GYPB
|
glycophorin B (MNS blood group)
|
|
GYPC
|
glycophorin C (Gerbich blood group)
|
|
GYPE
|
glycophorin E (MNS blood group)
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX)
|
|
GZMM
|
granzyme M (lymphocyte met-ase 1)
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAND1
|
heart and neural crest derivatives expressed 1
|
|
HAND2
|
heart and neural crest derivatives expressed 2
|
|
HAPLN1
|
hyaluronan and proteoglycan link protein 1
|
|
HAPLN2
|
hyaluronan and proteoglycan link protein 2
|
|
HAPLN3
|
hyaluronan and proteoglycan link protein 3
|
|
HAPLN4
|
hyaluronan and proteoglycan link protein 4
|
|
HAS1
|
hyaluronan synthase 1
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HCAR2
|
hydroxycarboxylic acid receptor 2
|
|
HCFC1
|
host cell factor C1
|
|
HCFC1R1
|
host cell factor C1 regulator 1 (XPO1 dependent)
|
|
HCFC2
|
host cell factor C2
|
|
HCG11
|
HLA complex group 11 (non-protein coding)
|
|
HCG14
|
HLA complex group 14 (non-protein coding)
|
|
HCG15
|
HLA complex group 15 (non-protein coding)
|
|
HCG16
|
HLA complex group 16 (non-protein coding)
|
|
HCG17
|
HLA complex group 17 (non-protein coding)
|
|
HCG18
|
HLA complex group 18 (non-protein coding)
|
|
HCG19P
|
HLA complex group 19 pseudogene
|
|
HCG20
|
HLA complex group 20 (non-protein coding)
|
|
HCG21
|
HLA complex group 21 (non-protein coding)
|
|
HCG22
|
HLA complex group 22
|
|
HCG23
|
HLA complex group 23 (non-protein coding)
|
|
HCG24
|
HLA complex group 24 (non-protein coding)
|
|
HCG25
|
HLA complex group 25 (non-protein coding)
|
|
HCG27
|
HLA complex group 27 (non-protein coding)
|
|
HCG4
|
HLA complex group 4 (non-protein coding)
|
|
HCG4P11
|
HLA complex group 4 pseudogene 11
|
|
HCG4P3
|
HLA complex group 4 pseudogene 3
|
|
HCG4P5
|
HLA complex group 4 pseudogene 5
|
|
HCG4P7
|
HLA complex group 4 pseudogene 7
|
|
HCG4P8
|
HLA complex group 4 pseudogene 8
|
|
HCG8
|
HLA complex group 8
|
|
HCG9
|
HLA complex group 9 (non-protein coding)
|
|
HCG9P5
|
HLA complex group 9 pseudogene 5
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HCP5
|
HLA complex P5 (non-protein coding)
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC4
|
histone deacetylase 4
|
|
HDAC5
|
histone deacetylase 5
|
|
HDAC6
|
histone deacetylase 6
|
|
HDAC7
|
histone deacetylase 7
|
|
HDAC9
|
histone deacetylase 9
|
|
HDC
|
histidine decarboxylase
|
|
HELLS
|
helicase, lymphoid-specific
|
|
HEPACAM
|
hepatic and glial cell adhesion molecule
|
|
HERPUD1
|
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HES5
|
hes family bHLH transcription factor 5
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HIATL1
|
hippocampus abundant transcript-like 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HINT1
|
histidine triad nucleotide binding protein 1
|
|
HINT2
|
histidine triad nucleotide binding protein 2
|
|
HIP1
|
huntingtin interacting protein 1
|
|
HIP1R
|
huntingtin interacting protein 1 related
|
|
HIPK1
|
homeodomain interacting protein kinase 1
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HIPK3
|
homeodomain interacting protein kinase 3
|
|
HIVEP1
|
human immunodeficiency virus type I enhancer binding protein 1
|
|
HIVEP2
|
human immunodeficiency virus type I enhancer binding protein 2
|
|
HIVEP3
|
human immunodeficiency virus type I enhancer binding protein 3
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
|
HLA-DOA
|
major histocompatibility complex, class II, DO alpha
|
|
HLA-DOB
|
major histocompatibility complex, class II, DO beta
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
|
HLA-DPA2
|
major histocompatibility complex, class II, DP alpha 2 (pseudogene)
|
|
HLA-DPA3
|
major histocompatibility complex, class II, DP alpha 3 (pseudogene)
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DPB2
|
major histocompatibility complex, class II, DP beta 2 (pseudogene)
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2
|
|
HLA-DQB3
|
major histocompatibility complex, class II, DQ beta 3
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB2
|
major histocompatibility complex, class II, DR beta 2 (pseudogene)
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5
|
|
HLA-DRB6
|
major histocompatibility complex, class II, DR beta 6 (pseudogene)
|
|
HLA-DRB7
|
major histocompatibility complex, class II, DR beta 7 (pseudogene)
|
|
HLA-DRB8
|
major histocompatibility complex, class II, DR beta 8 (pseudogene)
|
|
HLA-DRB9
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLA-H
|
major histocompatibility complex, class I, H (pseudogene)
|
|
HLA-J
|
major histocompatibility complex, class I, J (pseudogene)
|
|
HLA-K
|
major histocompatibility complex, class I, K (pseudogene)
|
|
HLA-L
|
major histocompatibility complex, class I, L (pseudogene)
|
|
HLA-N
|
major histocompatibility complex, class I, N (pseudogene)
|
|
HLA-P
|
major histocompatibility complex, class I, P (pseudogene)
|
|
HLA-S
|
major histocompatibility complex, class I, S (pseudogene)
|
|
HLA-T
|
major histocompatibility complex, class I, T (pseudogene)
|
|
HLA-U
|
major histocompatibility complex, class I, U (pseudogene)
|
|
HLA-W
|
major histocompatibility complex, class I, W (pseudogene)
|
|
HLA-Z
|
major histocompatibility complex, class I, Z (pseudogene)
|
|
HLF
|
hepatic leukemia factor
|
|
HM13
|
histocompatibility (minor) 13
|
|
HMGB1
|
high mobility group box 1
|
|
HMGB2
|
high mobility group box 2
|
|
HMHA1
|
histocompatibility (minor) HA-1
|
|
HMHB1
|
histocompatibility (minor) HB-1
|
|
HMOX1
|
heme oxygenase 1
|
|
HMSD
|
histocompatibility (minor) serpin domain containing
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNMT
|
histamine N-methyltransferase
|
|
HOOK2
|
hook microtubule-tethering protein 2
|
|
HOTAIRM1
|
HOXA transcript antisense RNA, myeloid-specific 1
|
|
HOXA13
|
homeobox A13
|
|
HOXA3
|
homeobox A3
|
|
HOXA5
|
homeobox A5
|
|
HOXA7
|
homeobox A7
|
|
HOXB4
|
homeobox B4
|
|
HOXB7
|
homeobox B7
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HPGDS
|
hematopoietic prostaglandin D synthase
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HPS1
|
Hermansky-Pudlak syndrome 1
|
|
HPS4
|
Hermansky-Pudlak syndrome 4
|
|
HPX
|
hemopexin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRG
|
histidine-rich glycoprotein
|
|
HRH1
|
histamine receptor H1
|
|
HRH2
|
histamine receptor H2
|
|
HRH3
|
histamine receptor H3
|
|
HRH4
|
histamine receptor H4
|
|
HRK
|
harakiri, BCL2 interacting protein
|
|
HS3ST5
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 5
|
|
HSBP1L1
|
heat shock factor binding protein 1-like 1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSH2D
|
hematopoietic SH2 domain containing
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB11
|
heat shock protein family B (small), member 11
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HSPE1
|
heat shock 10kDa protein 1
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
HTATIP2
|
HIV-1 Tat interactive protein 2, 30kDa
|
|
HTATSF1
|
HIV-1 Tat specific factor 1
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
|
HTR6
|
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HTT
|
huntingtin
|
|
IAPP
|
islet amyloid polypeptide
|
|
IBSP
|
integrin-binding sialoprotein
|
|
IBTK
|
inhibitor of Bruton agammaglobulinemia tyrosine kinase
|
|
ICA1
|
islet cell autoantigen 1, 69kDa
|
|
ICA1L
|
islet cell autoantigen 1,69kDa-like
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM2
|
intercellular adhesion molecule 2
|
|
ICAM3
|
intercellular adhesion molecule 3
|
|
ICAM4
|
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)
|
|
ICAM5
|
intercellular adhesion molecule 5, telencephalin
|
|
ICK
|
intestinal cell (MAK-like) kinase
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
IDE
|
insulin-degrading enzyme
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IER3
|
immediate early response 3
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFI27
|
interferon, alpha-inducible protein 27
|
|
IFI27L1
|
interferon, alpha-inducible protein 27-like 1
|
|
IFI27L2
|
interferon, alpha-inducible protein 27-like 2
|
|
IFI30
|
interferon, gamma-inducible protein 30
|
|
IFI35
|
interferon-induced protein 35
|
|
IFI44
|
interferon-induced protein 44
|
|
IFI44L
|
interferon-induced protein 44-like
|
|
IFI6
|
interferon, alpha-inducible protein 6
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1
|
|
IFIT1B
|
interferon-induced protein with tetratricopeptide repeats 1B
|
|
IFIT1P1
|
interferon-induced protein with tetratricopeptide repeats 1 pseudogene 1
|
|
IFIT2
|
interferon-induced protein with tetratricopeptide repeats 2
|
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3
|
|
IFIT5
|
interferon-induced protein with tetratricopeptide repeats 5
|
|
IFIT6P
|
interferon-induced protein with tetratricopeptide repeats 6, pseudogene
|
|
IFITM1
|
interferon induced transmembrane protein 1
|
|
IFITM2
|
interferon induced transmembrane protein 2
|
|
IFITM3
|
interferon induced transmembrane protein 3
|
|
IFITM4P
|
interferon induced transmembrane protein 4 pseudogene
|
|
IFITM5
|
interferon induced transmembrane protein 5
|
|
IFITM8P
|
interferon induced transmembrane protein 8 pseudogene
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA10
|
interferon, alpha 10
|
|
IFNA13
|
interferon, alpha 13
|
|
IFNA14
|
interferon, alpha 14
|
|
IFNA16
|
interferon, alpha 16
|
|
IFNA17
|
interferon, alpha 17
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNA21
|
interferon, alpha 21
|
|
IFNA22P
|
interferon, alpha 22, pseudogene
|
|
IFNA4
|
interferon, alpha 4
|
|
IFNA5
|
interferon, alpha 5
|
|
IFNA6
|
interferon, alpha 6
|
|
IFNA7
|
interferon, alpha 7
|
|
IFNA8
|
interferon, alpha 8
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNE
|
interferon, epsilon
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1)
|
|
IFNK
|
interferon, kappa
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL2
|
interferon, lambda 2
|
|
IFNL3
|
interferon, lambda 3
|
|
IFNLR1
|
interferon, lambda receptor 1
|
|
IFNNP1
|
interferon, nu 1, pseudogene
|
|
IFNW1
|
interferon, omega 1
|
|
IFNWP15
|
interferon, omega 1 pseudogene 15
|
|
IFNWP18
|
interferon, omega 1 pseudogene 18
|
|
IFNWP19
|
interferon, omega 1 pseudogene 19
|
|
IFNWP2
|
interferon, omega 1 pseudogene 2
|
|
IFNWP5
|
interferon, omega 1 pseudogene 5
|
|
IFNWP9
|
interferon, omega 1 pseudogene 9
|
|
IFRD1
|
interferon-related developmental regulator 1
|
|
IFRD2
|
interferon-related developmental regulator 2
|
|
IFT122
|
intraflagellar transport 122
|
|
IFT140
|
intraflagellar transport 140
|
|
IFT172
|
intraflagellar transport 172
|
|
IFT20
|
intraflagellar transport 20
|
|
IFT27
|
intraflagellar transport 27
|
|
IFT46
|
intraflagellar transport 46
|
|
IFT52
|
intraflagellar transport 52
|
|
IFT57
|
intraflagellar transport 57
|
|
IFT74
|
intraflagellar transport 74
|
|
IFT80
|
intraflagellar transport 80
|
|
IFT81
|
intraflagellar transport 81
|
|
IFT88
|
intraflagellar transport 88
|
|
IGBP1
|
immunoglobulin (CD79A) binding protein 1
|
|
IGBP1P1
|
immunoglobulin (CD79A) binding protein 1 pseudogene 1
|
|
IGDCC3
|
immunoglobulin superfamily, DCC subclass, member 3
|
|
IGDCC4
|
immunoglobulin superfamily, DCC subclass, member 4
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2-AS
|
IGF2 antisense RNA
|
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFALS
|
insulin-like growth factor binding protein, acid labile subunit
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGFN1
|
immunoglobulin-like and fibronectin type III domain containing 1
|
|
IGHA1
|
immunoglobulin heavy constant alpha 1
|
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker)
|
|
IGHD
|
immunoglobulin heavy constant delta
|
|
IGHD1-1
|
immunoglobulin heavy diversity 1-1
|
|
IGHD1-14
|
immunoglobulin heavy diversity 1-14 (non-functional)
|
|
IGHD1-20
|
immunoglobulin heavy diversity 1-20
|
|
IGHD1-26
|
immunoglobulin heavy diversity 1-26
|
|
IGHD1-7
|
immunoglobulin heavy diversity 1-7
|
|
IGHD2-15
|
immunoglobulin heavy diversity 2-15
|
|
IGHD2-2
|
immunoglobulin heavy diversity 2-2
|
|
IGHD2-21
|
immunoglobulin heavy diversity 2-21
|
|
IGHD2-8
|
immunoglobulin heavy diversity 2-8
|
|
IGHD3-10
|
immunoglobulin heavy diversity 3-10
|
|
IGHD3-16
|
immunoglobulin heavy diversity 3-16
|
|
IGHD3-22
|
immunoglobulin heavy diversity 3-22
|
|
IGHD3-3
|
immunoglobulin heavy diversity 3-3
|
|
IGHD3-9
|
immunoglobulin heavy diversity 3-9
|
|
IGHD4-11
|
immunoglobulin heavy diversity 4-11 (non-functional)
|
|
IGHD4-17
|
immunoglobulin heavy diversity 4-17
|
|
IGHD4-23
|
immunoglobulin heavy diversity 4-23 (non-functional)
|
|
IGHD4-4
|
immunoglobulin heavy diversity 4-4
|
|
IGHD5-12
|
immunoglobulin heavy diversity 5-12
|
|
IGHD5-18
|
immunoglobulin heavy diversity 5-18
|
|
IGHD5-24
|
immunoglobulin heavy diversity 5-24 (non-functional)
|
|
IGHD5-5
|
immunoglobulin heavy diversity 5-5
|
|
IGHD6-13
|
immunoglobulin heavy diversity 6-13
|
|
IGHD6-19
|
immunoglobulin heavy diversity 6-19
|
|
IGHD6-25
|
immunoglobulin heavy diversity 6-25
|
|
IGHD6-6
|
immunoglobulin heavy diversity 6-6
|
|
IGHD7-27
|
immunoglobulin heavy diversity 7-27
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IGHEP1
|
immunoglobulin heavy constant epsilon P1 (pseudogene)
|
|
IGHEP2
|
immunoglobulin heavy constant epsilon P2 (pseudogene)
|
|
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker)
|
|
IGHG2
|
immunoglobulin heavy constant gamma 2 (G2m marker)
|
|
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker)
|
|
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker)
|
|
IGHGP
|
immunoglobulin heavy constant gamma P (non-functional)
|
|
IGHJ1
|
immunoglobulin heavy joining 1
|
|
IGHJ1P
|
immunoglobulin heavy joining 1P (pseudogene)
|
|
IGHJ2
|
immunoglobulin heavy joining 2
|
|
IGHJ2P
|
immunoglobulin heavy joining 2P (pseudogene)
|
|
IGHJ3
|
immunoglobulin heavy joining 3
|
|
IGHJ3P
|
immunoglobulin heavy joining 3P (pseudogene)
|
|
IGHJ4
|
immunoglobulin heavy joining 4
|
|
IGHJ5
|
immunoglobulin heavy joining 5
|
|
IGHJ6
|
immunoglobulin heavy joining 6
|
|
IGHM
|
immunoglobulin heavy constant mu
|
|
IGHMBP2
|
immunoglobulin mu binding protein 2
|
|
IGHV1-12
|
immunoglobulin heavy variable 1-12 (pseudogene)
|
|
IGHV1-14
|
immunoglobulin heavy variable 1-14 (pseudogene)
|
|
IGHV1-17
|
immunoglobulin heavy variable 1-17 (pseudogene)
|
|
IGHV1-18
|
immunoglobulin heavy variable 1-18
|
|
IGHV1-2
|
immunoglobulin heavy variable 1-2
|
|
IGHV1-24
|
immunoglobulin heavy variable 1-24
|
|
IGHV1-3
|
immunoglobulin heavy variable 1-3
|
|
IGHV1-45
|
immunoglobulin heavy variable 1-45
|
|
IGHV1-46
|
immunoglobulin heavy variable 1-46
|
|
IGHV1-58
|
immunoglobulin heavy variable 1-58
|
|
IGHV1-67
|
immunoglobulin heavy variable 1-67 (pseudogene)
|
|
IGHV1-68
|
immunoglobulin heavy variable 1-68 (pseudogene)
|
|
IGHV1-69
|
immunoglobulin heavy variable 1-69
|
|
IGHV1-8
|
immunoglobulin heavy variable 1-8
|
|
IGHV1OR15-9
|
immunoglobulin heavy variable 1/OR15-9 (non-functional)
|
|
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional)
|
|
IGHV2-10
|
immunoglobulin heavy variable 2-10 (pseudogene)
|
|
IGHV2-26
|
immunoglobulin heavy variable 2-26
|
|
IGHV2-5
|
immunoglobulin heavy variable 2-5
|
|
IGHV2-70
|
immunoglobulin heavy variable 2-70
|
|
IGHV2OR16-5
|
immunoglobulin heavy variable 2/OR16-5 (non-functional)
|
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 (gene/pseudogene)
|
|
IGHV3-13
|
immunoglobulin heavy variable 3-13
|
|
IGHV3-15
|
immunoglobulin heavy variable 3-15
|
|
IGHV3-16
|
immunoglobulin heavy variable 3-16 (non-functional)
|
|
IGHV3-19
|
immunoglobulin heavy variable 3-19 (pseudogene)
|
|
IGHV3-20
|
immunoglobulin heavy variable 3-20
|
|
IGHV3-21
|
immunoglobulin heavy variable 3-21
|
|
IGHV3-22
|
immunoglobulin heavy variable 3-22 (pseudogene)
|
|
IGHV3-23
|
immunoglobulin heavy variable 3-23
|
|
IGHV3-25
|
immunoglobulin heavy variable 3-25 (pseudogene)
|
|
IGHV3-29
|
immunoglobulin heavy variable 3-29 (pseudogene)
|
|
IGHV3-30
|
immunoglobulin heavy variable 3-30
|
|
IGHV3-30-2
|
immunoglobulin heavy variable 3-30-2 (pseudogene)
|
|
IGHV3-32
|
immunoglobulin heavy variable 3-32 (pseudogene)
|
|
IGHV3-33
|
immunoglobulin heavy variable 3-33
|
|
IGHV3-33-2
|
immunoglobulin heavy variable 3-33-2 (pseudogene)
|
|
IGHV3-35
|
immunoglobulin heavy variable 3-35 (non-functional)
|
|
IGHV3-36
|
immunoglobulin heavy variable 3-36 (pseudogene)
|
|
IGHV3-37
|
immunoglobulin heavy variable 3-37 (pseudogene)
|
|
IGHV3-38
|
immunoglobulin heavy variable 3-38 (non-functional)
|
|
IGHV3-41
|
immunoglobulin heavy variable 3-41 (pseudogene)
|
|
IGHV3-42
|
immunoglobulin heavy variable 3-42 (pseudogene)
|
|
IGHV3-43
|
immunoglobulin heavy variable 3-43
|
|
IGHV3-47
|
immunoglobulin heavy variable 3-47 (pseudogene)
|
|
IGHV3-48
|
immunoglobulin heavy variable 3-48
|
|
IGHV3-49
|
immunoglobulin heavy variable 3-49
|
|
IGHV3-50
|
immunoglobulin heavy variable 3-50 (pseudogene)
|
|
IGHV3-52
|
immunoglobulin heavy variable 3-52 (pseudogene)
|
|
IGHV3-53
|
immunoglobulin heavy variable 3-53
|
|
IGHV3-54
|
immunoglobulin heavy variable 3-54 (pseudogene)
|
|
IGHV3-57
|
immunoglobulin heavy variable 3-57 (pseudogene)
|
|
IGHV3-6
|
immunoglobulin heavy variable 3-6 (pseudogene)
|
|
IGHV3-60
|
immunoglobulin heavy variable 3-60 (pseudogene)
|
|
IGHV3-62
|
immunoglobulin heavy variable 3-62 (pseudogene)
|
|
IGHV3-63
|
immunoglobulin heavy variable 3-63 (pseudogene)
|
|
IGHV3-64
|
immunoglobulin heavy variable 3-64
|
|
IGHV3-65
|
immunoglobulin heavy variable 3-65 (pseudogene)
|
|
IGHV3-66
|
immunoglobulin heavy variable 3-66
|
|
IGHV3-7
|
immunoglobulin heavy variable 3-7
|
|
IGHV3-71
|
immunoglobulin heavy variable 3-71 (pseudogene)
|
|
IGHV3-72
|
immunoglobulin heavy variable 3-72
|
|
IGHV3-73
|
immunoglobulin heavy variable 3-73
|
|
IGHV3-74
|
immunoglobulin heavy variable 3-74
|
|
IGHV3-75
|
immunoglobulin heavy variable 3-75 (pseudogene)
|
|
IGHV3-76
|
immunoglobulin heavy variable 3-76 (pseudogene)
|
|
IGHV3-79
|
immunoglobulin heavy variable 3-79 (pseudogene)
|
|
IGHV3-9
|
immunoglobulin heavy variable 3-9
|
|
IGHV3OR16-8
|
immunoglobulin heavy variable 3/OR16-8 (non-functional)
|
|
IGHV4-28
|
immunoglobulin heavy variable 4-28
|
|
IGHV4-31
|
immunoglobulin heavy variable 4-31
|
|
IGHV4-34
|
immunoglobulin heavy variable 4-34
|
|
IGHV4-39
|
immunoglobulin heavy variable 4-39
|
|
IGHV4-4
|
immunoglobulin heavy variable 4-4
|
|
IGHV4-55
|
immunoglobulin heavy variable 4-55 (pseudogene)
|
|
IGHV4-59
|
immunoglobulin heavy variable 4-59
|
|
IGHV4-61
|
immunoglobulin heavy variable 4-61
|
|
IGHV4-80
|
immunoglobulin heavy variable 4-80 (pseudogene)
|
|
IGHV4OR15-8
|
immunoglobulin heavy variable 4/OR15-8 (non-functional)
|
|
IGHV5-51
|
immunoglobulin heavy variable 5-51
|
|
IGHV5-78
|
immunoglobulin heavy variable 5-78 (pseudogene)
|
|
IGHV6-1
|
immunoglobulin heavy variable 6-1
|
|
IGHV7-27
|
immunoglobulin heavy variable 7-27 (pseudogene)
|
|
IGHV7-34-1
|
immunoglobulin heavy variable 7-34-1 (pseudogene)
|
|
IGHV7-40
|
immunoglobulin heavy variable 7-40 (pseudogene)
|
|
IGHV7-56
|
immunoglobulin heavy variable 7-56 (pseudogene)
|
|
IGHV7-81
|
immunoglobulin heavy variable 7-81 (non-functional)
|
|
IGHVII-1-1
|
immunoglobulin heavy variable (II)-1-1 (pseudogene)
|
|
IGHVII-15-1
|
immunoglobulin heavy variable (II)-15-1 (pseudogene)
|
|
IGHVII-20-1
|
immunoglobulin heavy variable (II)-20-1 (pseudogene)
|
|
IGHVII-22-1
|
immunoglobulin heavy variable (II)-22-1 (pseudogene)
|
|
IGHVII-26-2
|
immunoglobulin heavy variable (II)-26-2 (pseudogene)
|
|
IGHVII-28-1
|
immunoglobulin heavy variable (II)-28-1 (pseudogene)
|
|
IGHVII-30-1
|
immunoglobulin heavy variable (II)-30-1 (pseudogene)
|
|
IGHVII-31-1
|
immunoglobulin heavy variable (II)-31-1 (pseudogene)
|
|
IGHVII-33-1
|
immunoglobulin heavy variable (II)-33-1 (pseudogene)
|
|
IGHVII-40-1
|
immunoglobulin heavy variable (II)-40-1 (pseudogene)
|
|
IGHVII-43-1
|
immunoglobulin heavy variable (II)-43-1 (pseudogene)
|
|
IGHVII-44-2
|
immunoglobulin heavy variable (II)-44-2 (pseudogene)
|
|
IGHVII-46-1
|
immunoglobulin heavy variable (II)-46-1 (pseudogene)
|
|
IGHVII-49-1
|
immunoglobulin heavy variable (II)-49-1 (pseudogene)
|
|
IGHVII-51-2
|
immunoglobulin heavy variable (II)-51-2 (pseudogene)
|
|
IGHVII-53-1
|
immunoglobulin heavy variable (II)-53-1 (pseudogene)
|
|
IGHVII-60-1
|
immunoglobulin heavy variable (II)-60-1 (pseudogene)
|
|
IGHVII-62-1
|
immunoglobulin heavy variable (II)-62-1 (pseudogene)
|
|
IGHVII-65-1
|
immunoglobulin heavy variable (II)-65-1 (pseudogene)
|
|
IGHVII-67-1
|
immunoglobulin heavy variable (II)-67-1 (pseudogene)
|
|
IGHVII-74-1
|
immunoglobulin heavy variable (II)-74-1 (pseudogene)
|
|
IGHVII-78-1
|
immunoglobulin heavy variable (II)-78-1 (pseudogene)
|
|
IGHVIII-11-1
|
immunoglobulin heavy variable (III)-11-1 (pseudogene)
|
|
IGHVIII-13-1
|
immunoglobulin heavy variable (III)-13-1 (pseudogene)
|
|
IGHVIII-16-1
|
immunoglobulin heavy variable (III)-16-1 (pseudogene)
|
|
IGHVIII-2-1
|
immunoglobulin heavy variable (III)-2-1 (pseudogene)
|
|
IGHVIII-22-2
|
immunoglobulin heavy variable (III)-22-2 (pseudogene)
|
|
IGHVIII-25-1
|
immunoglobulin heavy variable (III)-25-1 (pseudogene)
|
|
IGHVIII-26-1
|
immunoglobulin heavy variable (III)-26-1 (pseudogene)
|
|
IGHVIII-38-1
|
immunoglobulin heavy variable (III)-38-1 (pseudogene)
|
|
IGHVIII-44
|
immunoglobulin heavy variable (III)-44 (pseudogene)
|
|
IGHVIII-47-1
|
immunoglobulin heavy variable (III)-47-1 (pseudogene)
|
|
IGHVIII-5-1
|
immunoglobulin heavy variable (III)-5-1 (pseudogene)
|
|
IGHVIII-5-2
|
immunoglobulin heavy variable (III)-5-2 (pseudogene)
|
|
IGHVIII-51-1
|
immunoglobulin heavy variable (III)-51-1 (pseudogene)
|
|
IGHVIII-67-2
|
immunoglobulin heavy variable (III)-67-2 (pseudogene)
|
|
IGHVIII-67-3
|
immunoglobulin heavy variable (III)-67-3 (pseudogene)
|
|
IGHVIII-67-4
|
immunoglobulin heavy variable (III)-67-4 (pseudogene)
|
|
IGHVIII-76-1
|
immunoglobulin heavy variable (III)-76-1 (pseudogene)
|
|
IGHVIII-82
|
immunoglobulin heavy variable (III)-82 (pseudogene)
|
|
IGHVIV-44-1
|
immunoglobulin heavy variable (IV)-44-1 (pseudogene)
|
|
IGJP1
|
immunoglobulin J polypeptide pseudogene 1
|
|
IGKC
|
immunoglobulin kappa constant
|
|
IGKJ1
|
immunoglobulin kappa joining 1
|
|
IGKJ2
|
immunoglobulin kappa joining 2
|
|
IGKJ3
|
immunoglobulin kappa joining 3
|
|
IGKJ4
|
immunoglobulin kappa joining 4
|
|
IGKJ5
|
immunoglobulin kappa joining 5
|
|
IGKV1-12
|
immunoglobulin kappa variable 1-12
|
|
IGKV1-13
|
immunoglobulin kappa variable 1-13 (gene/pseudogene)
|
|
IGKV1-16
|
immunoglobulin kappa variable 1-16
|
|
IGKV1-17
|
immunoglobulin kappa variable 1-17
|
|
IGKV1-22
|
immunoglobulin kappa variable 1-22 (pseudogene)
|
|
IGKV1-27
|
immunoglobulin kappa variable 1-27
|
|
IGKV1-32
|
immunoglobulin kappa variable 1-32 (pseudogene)
|
|
IGKV1-33
|
immunoglobulin kappa variable 1-33
|
|
IGKV1-35
|
immunoglobulin kappa variable 1-35 (pseudogene)
|
|
IGKV1-37
|
immunoglobulin kappa variable 1-37 (non-functional)
|
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene)
|
|
IGKV1-5
|
immunoglobulin kappa variable 1-5
|
|
IGKV1-6
|
immunoglobulin kappa variable 1-6
|
|
IGKV1-8
|
immunoglobulin kappa variable 1-8
|
|
IGKV1-9
|
immunoglobulin kappa variable 1-9
|
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12
|
|
IGKV1D-13
|
immunoglobulin kappa variable 1D-13
|
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16
|
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17
|
|
IGKV1D-22
|
immunoglobulin kappa variable 1D-22 (pseudogene)
|
|
IGKV1D-27
|
immunoglobulin kappa variable 1D-27 (pseudogene)
|
|
IGKV1D-32
|
immunoglobulin kappa variable 1D-32 (pseudogene)
|
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33
|
|
IGKV1D-35
|
immunoglobulin kappa variable 1D-35 (pseudogene)
|
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional)
|
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39
|
|
IGKV1D-42
|
immunoglobulin kappa variable 1D-42 (non-functional)
|
|
IGKV1D-43
|
immunoglobulin kappa variable 1D-43
|
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8
|
|
IGKV1OR22-1
|
immunoglobulin kappa variable 1/OR22-1 (pseudogene)
|
|
IGKV2-10
|
immunoglobulin kappa variable 2-10 (pseudogene)
|
|
IGKV2-14
|
immunoglobulin kappa variable 2-14 (pseudogene)
|
|
IGKV2-18
|
immunoglobulin kappa variable 2-18 (pseudogene)
|
|
IGKV2-19
|
immunoglobulin kappa variable 2-19 (pseudogene)
|
|
IGKV2-23
|
immunoglobulin kappa variable 2-23 (pseudogene)
|
|
IGKV2-24
|
immunoglobulin kappa variable 2-24
|
|
IGKV2-26
|
immunoglobulin kappa variable 2-26 (pseudogene)
|
|
IGKV2-28
|
immunoglobulin kappa variable 2-28
|
|
IGKV2-29
|
immunoglobulin kappa variable 2-29 (gene/pseudogene)
|
|
IGKV2-30
|
immunoglobulin kappa variable 2-30
|
|
IGKV2-36
|
immunoglobulin kappa variable 2-36 (pseudogene)
|
|
IGKV2-38
|
immunoglobulin kappa variable 2-38 (pseudogene)
|
|
IGKV2-4
|
immunoglobulin kappa variable 2-4 (pseudogene)
|
|
IGKV2-40
|
immunoglobulin kappa variable 2-40
|
|
IGKV2D-10
|
immunoglobulin kappa variable 2D-10 (pseudogene)
|
|
IGKV2D-14
|
immunoglobulin kappa variable 2D-14 (pseudogene)
|
|
IGKV2D-18
|
immunoglobulin kappa variable 2D-18 (pseudogene)
|
|
IGKV2D-19
|
immunoglobulin kappa variable 2D-19 (pseudogene)
|
|
IGKV2D-23
|
immunoglobulin kappa variable 2D-23 (pseudogene)
|
|
IGKV2D-24
|
immunoglobulin kappa variable 2D-24 (non-functional)
|
|
IGKV2D-26
|
immunoglobulin kappa variable 2D-26
|
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28
|
|
IGKV2D-29
|
immunoglobulin kappa variable 2D-29
|
|
IGKV2D-30
|
immunoglobulin kappa variable 2D-30
|
|
IGKV2D-36
|
immunoglobulin kappa variable 2D-36 (pseudogene)
|
|
IGKV2D-38
|
immunoglobulin kappa variable 2D-38 (pseudogene)
|
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40
|
|
IGKV2OR22-3
|
immunoglobulin kappa variable 2/OR22-3 (pseudogene)
|
|
IGKV2OR22-4
|
immunoglobulin kappa variable 2/OR22-4 (pseudogene)
|
|
IGKV3-11
|
immunoglobulin kappa variable 3-11
|
|
IGKV3-15
|
immunoglobulin kappa variable 3-15
|
|
IGKV3-20
|
immunoglobulin kappa variable 3-20
|
|
IGKV3-25
|
immunoglobulin kappa variable 3-25 (pseudogene)
|
|
IGKV3-31
|
immunoglobulin kappa variable 3-31 (pseudogene)
|
|
IGKV3-34
|
immunoglobulin kappa variable 3-34 (pseudogene)
|
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional)
|
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11
|
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene)
|
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20
|
|
IGKV3D-25
|
immunoglobulin kappa variable 3D-25 (pseudogene)
|
|
IGKV3D-31
|
immunoglobulin kappa variable 3D-31 (pseudogene)
|
|
IGKV3D-34
|
immunoglobulin kappa variable 3D-34 (pseudogene)
|
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7
|
|
IGKV3OR22-2
|
immunoglobulin kappa variable 3/OR22-2 (pseudogene)
|
|
IGKV4-1
|
immunoglobulin kappa variable 4-1
|
|
IGKV5-2
|
immunoglobulin kappa variable 5-2
|
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional)
|
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional)
|
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional)
|
